MPSK1
Normalized values from positional scanning peptide array
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
S Sites Probabilities
T Sites Probabilities
Log-Odds: S Sites / S Background
Log-Odds: T Sites / T Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| O15085 | S1295 | Sugiyama | ARHGEF11 KIAA0380 | PEQEDMGLCSLEHLPPRtRNsGIWEsPELDRNLAEDASSTE |
| O15085 | T1292 | Sugiyama | ARHGEF11 KIAA0380 | GERPEQEDMGLCSLEHLPPRtRNsGIWEsPELDRNLAEDAS |
| O15371 | T46 | Sugiyama | EIF3D EIF3S7 | RDMPyQPFsKGDRLGKVADWtGAtyQDKRYTNKYSSQFGGG |
| O43390 | T134 | Sugiyama | HNRNPR HNRPR | KVQESTKGPDEAKIKALLERtGytLDVttGQRKYGGPPPDS |
| O43390 | T142 | Sugiyama | HNRNPR HNRPR | PDEAKIKALLERtGytLDVttGQRKYGGPPPDSVYSGVQPG |
| O60506 | T131 | Sugiyama | SYNCRIP HNRPQ NSAP1 | KVADSSKGPDEAKIKALLERtGytLDVttGQRKYGGPPPDS |
| O60506 | T139 | Sugiyama | SYNCRIP HNRPQ NSAP1 | PDEAKIKALLERtGytLDVttGQRKYGGPPPDSVYSGQQPs |
| O75716 | S197 | GPS6|SIGNOR|EPSD|PSP | STK16 MPSK1 PKL12 TSF1 | VEGSRQALtLQDWAAQRCTIsyRAPELFSVQSHCVIDERTD |
| O75716 | T185 | GPS6|SIGNOR|EPSD|PSP | STK16 MPSK1 PKL12 TSF1 | MDLGSMNQACIHVEGSRQALtLQDWAAQRCTIsyRAPELFS |
| O75716 | Y198 | SIGNOR|EPSD|PSP | STK16 MPSK1 PKL12 TSF1 | EGSRQALtLQDWAAQRCTIsyRAPELFSVQSHCVIDERTDV |
| O96019 | T72 | Sugiyama | ACTL6A BAF53 BAF53A INO80K | TLMEIDGDKGKQGGPtyyIDtNALRVPRENMEAIsPLKNGM |
| P00491 | S163 | Sugiyama | PNP NP | GQNPLRGPNDERFGDRFPAMsDAyDRtMRQRALstWKQMGE |
| P00966 | T208 | Sugiyama | ASS1 ASS | IsyEAGILENPKNQAPPGLytKtQDPAKAPNtPDILEIEFK |
| P04040 | T29 | Sugiyama | CAT | SDQMQHWKEQRAAQKADVLttGAGNPVGDKLNVItVGPRGP |
| P04075 | T37 | Sugiyama | ALDOA ALDA | sDIAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRR |
| P04083 | S201 | Sugiyama | ANXA1 ANX1 LPC1 | LsLAKGDRsEDFGVNEDLADsDARALyEAGERRKGtDVNVF |
| P04406 | T211 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | PsGKLWRDGRGALQNIIPAstGAAKAVGKVIPELNGKLtGM |
| P04406 | T246 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | GKLtGMAFRVPtANVsVVDLtCRLEKPAKyDDIKKVVKQAS |
| P04792 | S82 | Sugiyama | HSPB1 HSP27 HSP28 | AIEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVN |
| P05386 | S104 | Sugiyama | RPLP1 RRP1 | tAAAPAEEKKVEAKKEEsEEsDDDMGFGLFD__________ |
| P05387 | S105 | Sugiyama | RPLP2 D11S2243E RPP2 | GsAPAAAEEKKDEKKEEsEEsDDDMGFGLFD__________ |
| P06733 | T205 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | GAEVyHNLKNVIKEKyGKDAtNVGDEGGFAPNILENKEGLE |
| P07437 | T55 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | tyHGDsDLQLDRIsVyyNEAtGGKyVPRAILVDLEPGtMDs |
| P07900 | S50 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | MSLIINtFySNKEIFLRELIsNssDALDKIRyEsLtDPsKL |
| P08195 | T599 | Sugiyama | SLC3A2 MDU1 | QASDLPASASLPAKADLLLstQPGREEGsPLELERLKLEPH |
| P08238 | S45 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | MSLIINTFYSNKEIFLRELIsNAsDALDKIRyEsLtDPsKL |
| P08238 | S462 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | HEDstNRRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKs |
| P08238 | S468 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | RRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKsIyyItG |
| P08238 | T89 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | KELKIDIIPNPQERtLtLVDtGIGMtKADLINNLGtIAKSG |
| P08865 | T94 | Sugiyama | RPSA LAMBR LAMR1 | VsVIssRNtGQRAVLKFAAAtGAtPIAGRFtPGTFTNQIQA |
| P09382 | S63 | Sugiyama | LGALS1 | CLHFNPRFNAHGDANtIVCNsKDGGAWGTEQREAVFPFQPG |
| P11142 | T45 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | KVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAMNPtN |
| P13861 | S99 | Sugiyama | PRKAR2A PKR2 PRKAR2 | EsEEDEDLEVPVPsRFNRRVsVCAEtyNPDEEEEDTDPRVI |
| P14625 | S106 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | MKLIINSLYKNKEIFLRELIsNAsDALDKIRLISLTDENAL |
| P14625 | T519 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | DHsNRtRLAKLLRFQssHHPtDItsLDQyVERMKEKQDKIy |
| P14625 | T522 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | NRtRLAKLLRFQssHHPtDItsLDQyVERMKEKQDKIyFMA |
| P14625 | T675 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | sGNMERIMKAQAYQtGKDIstNyyAsQKKTFEINPRHPLIR |
| P15259 | T96 | Sugiyama | PGAM2 PGAMM | QMWLPVVRTWRLNERHyGGLtGLNKAETAAKHGEEQVKIWR |
| P17066 | T47 | Sugiyama | HSPA6 HSP70B' | RVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAALNPHN |
| P18669 | T96 | Sugiyama | PGAM1 PGAMA CDABP0006 | QMWLPVVRTWRLNERHyGGLtGLNKAETAAKHGEAQVKIWR |
| P19338 | T464 | Sugiyama | NCL | KTFEEKQGtEIDGRsIsLyytGEKGQNQDYRGGKNSTWsGE |
| P20290 | T182 | Sugiyama | BTF3 NACB OK/SW-cl.8 | LRRLAEALPKQsVDGKAPLAtGEDDDDEVPDLVENFDEAsK |
| P20618 | Y158 | Sugiyama | PSMB1 PSC5 | IGGLDEEGKGAVysFDPVGsyQRDsFKAGGSASAMLQPLLD |
| P22626 | S225 | Sugiyama | HNRNPA2B1 HNRPA2B1 | GNFGFGDsRGGGGNFGPGPGsNFRGGsDGyGsGRGFGDGyN |
| P27448 | S42 | Sugiyama | MARK3 CTAK1 EMK2 | GDGRQEVTSRTSRSGARCRNsIAsCADEQPHIGNyRLLKTI |
| P27448 | S45 | Sugiyama | MARK3 CTAK1 EMK2 | RQEVTSRTSRSGARCRNsIAsCADEQPHIGNyRLLKTIGKG |
| P29692 | S162 | Sugiyama | EEF1D EF1D | AKKPAtPAEDDEDDDIDLFGsDNEEEDKEAAQLREERLRQY |
| P29692 | S70 | Sugiyama | EEF1D EF1D | IARARENIQKsLAGssGPGAssGtsGDHGELVVRIAsLEVE |
| P30041 | T48 | Sugiyama | PRDX6 AOP2 KIAA0106 | FLGDSWGILFSHPRDFtPVCttELGRAAKLAPEFAKRNVKL |
| P30050 | S157 | Sugiyama | RPL12 | QsVGCNVDGRHPHDIIDDINsGAVECPAs____________ |
| P34931 | T47 | Sugiyama | HSPA1L | KVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAMNPQN |
| P35269 | S449 | Sugiyama | GTF2F1 RAP74 | PQsLsGKstPQPPsGKttPNsGDVQVTEDAVRRYLTRKPMT |
| P35611 | T16 | Sugiyama | ADD1 ADDA | _____MNGDsRAAVVtsPPPttAPHKERyFDRVDENNPEyL |
| P37802 | T180 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | RNFsDNQLQEGKNVIGLQMGtNRGAsQAGMtGyGMPRQIL_ |
| P38646 | T111 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | VAFtADGERLVGMPAKRQAVtNPNNtFyAtKRLIGRRYDDP |
| P38646 | T94 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | QAKVLENAEGARttPsVVAFtADGERLVGMPAKRQAVtNPN |
| P39023 | S13 | Sugiyama | RPL3 OK/SW-cl.32 | ________MSHRKFSAPRHGsLGFLPRKRSSRHRGKVKSFP |
| P43243 | S188 | Sugiyama | MATR3 KIAA0723 | EPPyRVPRDDWEEKRHFRRDsFDDRGPsLNPVLDyDHGsRs |
| P46777 | S172 | Sugiyama | RPL5 MSTP030 | RTTTGNKVFGALKGAVDGGLsIPHstKRFPGyDsEsKEFNA |
| P46777 | S176 | Sugiyama | RPL5 MSTP030 | GNKVFGALKGAVDGGLsIPHstKRFPGyDsEsKEFNAEVHR |
| P47712 | S454 | Sugiyama | PLA2G4A CPLA2 PLA2G4 | ssDsDDEsHEPKGtENEDAGsDyQsDNQASWIHRMIMALVS |
| P48643 | T269 | Sugiyama | CCT5 CCTE KIAA0098 | AILTCPFEPPKPKTKHKLDVtsVEDyKALQKYEKEKFEEMI |
| P48741 | T47 | Sugiyama | HSPA7 HSP70B | RVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAALNPHN |
| P49411 | T276 | Sugiyama | TUFM | DLEKPFLLPVEAVYSVPGRGtVVTGTLERGILKKGDECELL |
| P50990 | T286 | Sugiyama | CCT8 C21orf112 CCTQ KIAA0002 | MNFsKGEENLMDAQVKAIADtGANVVVtGGKVADMALHYAN |
| P53621 | S266 | Sugiyama | COPA | RGHyNNVSCAVFHPRQELILsNsEDKSIRVWDMSKRTGVQT |
| P54652 | T46 | Sugiyama | HSPA2 | KVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAMNPTN |
| P60174 | S212 | Sugiyama | TPI1 TPI | WLKsNVsDAVAQstRIIyGGsVtGAtCKELASQPDVDGFLV |
| P60709 | S323 | Sugiyama | ACTB | ttMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGG |
| P61254 | T8 | Sugiyama | RPL26 | _____________MKFNPFVtsDRsKNRKRHFNAPsHIRRK |
| P61978 | S81 | Sugiyama | HNRNPK HNRPK | GGKNIKALRtDyNAsVsVPDssGPERILsISADIETIGEIL |
| P62191 | T230 | Sugiyama | PSMC1 | yyEEMGIKPPKGVILyGPPGtGKTLLAKAVANQTsATFLRV |
| P62249 | S9 | Sugiyama | RPS16 | ____________MPsKGPLQsVQVFGRKKTATAVAHCKRGN |
| P62263 | S137 | Sugiyama | RPS14 PRO2640 | RALARSGMKIGRIEDVtPIPsDstRRKGGRRGRRL______ |
| P62273 | Y7 | Sugiyama | RPS29 | ______________MGHQQLyWsHPRKFGQGSRSCRVCSNR |
| P62736 | S325 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P62826 | T66 | Sugiyama | RAN ARA24 OK/SW-cl.81 | EVHPLVFHTNRGPIKFNVWDtAGQEKFGGLRDGYYIQAQCA |
| P62942 | T28 | Sugiyama | FKBP1A FKBP1 FKBP12 | IsPGDGRtFPKRGQtCVVHytGMLEDGKKFDSSRDRNKPFK |
| P63173 | T14 | Sugiyama | RPL38 | _______MPRKIEEIKDFLLtARRKDAKSVKIKKNKDNVKF |
| P63261 | S323 | Sugiyama | ACTG1 ACTG | ttMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGG |
| P63267 | S324 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P68032 | S325 | Sugiyama | ACTC1 ACTC | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P68133 | S325 | Sugiyama | ACTA1 ACTA | TTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P78371 | T242 | Sugiyama | CCT2 99D8.1 CCTB | KKIGVNQPKRIENAKILIANtGMDtDKIKIFGsRVRVDstA |
| Q00613 | S363 | Sugiyama | HSF1 HSTF1 | AsVTALtDARGHTDtEGRPPsPPPtstPEKCLsVACLDKNE |
| Q12805 | S382 | Sugiyama | EFEMP1 FBLN3 FBNL | RNPCQDPyILTPENRCVCPVsNAMCRELPQSIVYKYMSIRS |
| Q13247 | S303 | Sugiyama | SRSF6 SFRS6 SRP55 | ENGKGDIKsKSRsRsQsRsNsPLPVPPsKARsVsPPPKRAT |
| Q13283 | S232 | Sugiyama | G3BP1 G3BP | EEKPEPVLEETAPEDAQKsssPAPADIAQtVQEDLRtFsWA |
| Q14568 | S50 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | MSLIINTFYSNKEIFLRELIsNssDALDKIWYESLTDPSKL |
| Q14847 | T104 | Sugiyama | LASP1 MLN50 | VRYKEEFEKNKGKGFsVVADtPELQRIKKTQDQIsNIKyHE |
| Q16543 | T370 | Sugiyama | CDC37 CDC37A | EAKEGEEAGPGDPLLEAVPKtGDEKDVsV____________ |
| Q562R1 | T107 | Sugiyama | ACTBL2 | WYHTFYNELRVAPDEHPILLtEAPLNPKINREKMTQIMFEA |
| Q6PKG0 | T747 | Sugiyama | LARP1 KIAA0731 LARP | PPVDPNQEVPPGPPRFQQVPtDALANKLFGAPEPstIARsL |
| Q8IZ73 | T407 | Sugiyama | RPUSD2 C15orf19 | PIYNSVAWGPSRGRGGYIPKtNEELLRDLVAEHQAKQSLDV |
| Q8N0Y7 | T96 | Sugiyama | PGAM4 PGAM3 | QMWLPVVRTWRLNERHyGGLtGLNKAETAAKHGEAQVKIWR |
| Q8NFD5 | S1744 | Sugiyama | ARID1B BAF250B DAN15 KIAA1235 OSA2 | ALDTINILLYDDSTVATFNLsQLSGFLELLVEYFRKCLIDI |
| Q92615 | S589 | Sugiyama | LARP4B KIAA0217 LARP5 | ADAsVNtLPVVVSREPsVPAsCAVsAtyERsPsPAHLPDDP |
| Q9BQE3 | S439 | Sugiyama | TUBA1C TUBA6 | SEAREDMAALEKDyEEVGADsADGEDEGEEy__________ |
| Q9BX95 | S112 | Sugiyama | SGPP1 SPP1 | GLAAELGPAsPRRAGALRRNsLtGEEGQLARVSNWPLYCLF |
| Q9H7N4 | S498 | Sugiyama | SCAF1 SFRS19 SRA1 | GGLDLRRKILTQRRERyRQRsPsPAPAPAPAAAAGPPTRKK |
| Q9H7N4 | S500 | Sugiyama | SCAF1 SFRS19 SRA1 | LDLRRKILTQRRERyRQRsPsPAPAPAPAAAAGPPTRKKSR |
| Q9UNX3 | T8 | Sugiyama | RPL26L1 RPL26P1 | _____________MKFNPFVtsDRsKNRKRHFNAPSHVRRK |
| Q9UQ35 | S2132 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | SRMsCFsRPsMsPtPLDRCRsPGMLEPLGssRtPMsVLQQA |
| Q9Y285 | T504 | Sugiyama | FARSA FARS FARSL FARSLA | LQMVYDsPLCRLDAEPRPPPtQEAA________________ |
| Q9Y295 | T100 | GPS6|SIGNOR | DRG1 NEDD3 | LLSNLAGVYSEVAAYEFTTLttVPGVIRYKGAKIQLLDLPG |
| Q9Y295 | T101 | PSP | DRG1 NEDD3 | LSNLAGVYSEVAAYEFTTLttVPGVIRYKGAKIQLLDLPGI |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Chromatin modifying enzymes | R-HSA-3247509 | 3.098537e-09 | 8.509 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 4.073303e-09 | 8.390 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 2.691482e-06 | 5.570 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 3.044219e-06 | 5.517 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 9.289198e-06 | 5.032 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 3.090988e-05 | 4.510 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 5.443503e-05 | 4.264 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 5.497780e-05 | 4.260 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 5.934598e-05 | 4.227 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 4.654863e-05 | 4.332 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 1.483879e-04 | 3.829 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 2.380580e-04 | 3.623 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 3.067399e-04 | 3.513 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 3.211143e-04 | 3.493 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 3.880204e-04 | 3.411 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 4.285361e-04 | 3.368 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 6.320222e-04 | 3.199 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 8.777951e-04 | 3.057 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 8.667240e-04 | 3.062 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 9.501207e-04 | 3.022 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 1.452131e-03 | 2.838 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 1.487542e-03 | 2.828 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 1.704565e-03 | 2.768 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 1.834933e-03 | 2.736 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 2.167479e-03 | 2.664 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 2.204715e-03 | 2.657 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 2.379181e-03 | 2.624 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 2.814646e-03 | 2.551 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 2.837041e-03 | 2.547 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 2.814646e-03 | 2.551 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 3.013184e-03 | 2.521 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 3.088326e-03 | 2.510 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 3.425366e-03 | 2.465 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 3.519437e-03 | 2.454 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 3.671545e-03 | 2.435 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 4.125896e-03 | 2.384 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 5.454227e-03 | 2.263 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 5.331325e-03 | 2.273 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 6.224276e-03 | 2.206 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 6.240823e-03 | 2.205 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 5.885657e-03 | 2.230 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 6.224276e-03 | 2.206 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 7.004637e-03 | 2.155 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 1.383915e-02 | 1.859 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 9.305083e-03 | 2.031 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 1.210703e-02 | 1.917 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 7.679713e-03 | 2.115 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 9.175206e-03 | 2.037 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 1.154968e-02 | 1.937 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 1.154968e-02 | 1.937 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 1.383915e-02 | 1.859 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 1.196286e-02 | 1.922 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 1.196286e-02 | 1.922 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 1.196286e-02 | 1.922 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 1.087777e-02 | 1.963 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 1.280325e-02 | 1.893 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 1.040212e-02 | 1.983 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 1.376212e-02 | 1.861 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 7.962258e-03 | 2.099 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 7.266655e-03 | 2.139 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 7.718083e-03 | 2.112 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 8.265147e-03 | 2.083 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 1.196286e-02 | 1.922 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 9.999609e-03 | 2.000 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 1.323365e-02 | 1.878 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 9.212807e-03 | 2.036 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 1.323365e-02 | 1.878 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 1.083893e-02 | 1.965 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 1.124788e-02 | 1.949 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 1.385449e-02 | 1.858 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 9.644321e-03 | 2.016 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 9.999609e-03 | 2.000 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 8.577612e-03 | 2.067 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 8.577612e-03 | 2.067 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 9.644321e-03 | 2.016 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 1.190986e-02 | 1.924 | 0 | 0 |
| Regulation of TP53 Expression | R-HSA-6804754 | 1.426760e-02 | 1.846 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 1.545872e-02 | 1.811 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 1.545872e-02 | 1.811 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 1.614356e-02 | 1.792 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 1.614356e-02 | 1.792 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 1.734170e-02 | 1.761 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 1.734170e-02 | 1.761 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 1.742800e-02 | 1.759 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 1.808355e-02 | 1.743 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 1.875942e-02 | 1.727 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 1.869391e-02 | 1.728 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 1.962154e-02 | 1.707 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 1.936546e-02 | 1.713 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 2.007162e-02 | 1.697 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 2.044050e-02 | 1.690 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 2.087183e-02 | 1.680 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 2.140290e-02 | 1.670 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 2.140290e-02 | 1.670 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 2.587823e-02 | 1.587 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 2.587823e-02 | 1.587 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 2.587823e-02 | 1.587 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 2.587823e-02 | 1.587 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 2.456419e-02 | 1.610 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 2.516973e-02 | 1.599 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 2.456419e-02 | 1.610 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 2.431817e-02 | 1.614 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 2.291093e-02 | 1.640 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 2.297697e-02 | 1.639 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 2.587823e-02 | 1.587 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 2.486861e-02 | 1.604 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 2.360691e-02 | 1.627 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 2.390986e-02 | 1.621 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 2.516973e-02 | 1.599 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 2.603259e-02 | 1.584 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 2.621828e-02 | 1.581 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 2.673822e-02 | 1.573 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 2.673822e-02 | 1.573 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 3.027794e-02 | 1.519 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 3.027794e-02 | 1.519 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 3.027794e-02 | 1.519 | 0 | 0 |
| Signaling by MAP2K mutants | R-HSA-9652169 | 3.027794e-02 | 1.519 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 3.081537e-02 | 1.511 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 3.377681e-02 | 1.471 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 3.166650e-02 | 1.499 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 3.262292e-02 | 1.486 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 2.805413e-02 | 1.552 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 3.262292e-02 | 1.486 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 3.081537e-02 | 1.511 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 3.081537e-02 | 1.511 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 3.060437e-02 | 1.514 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 2.708026e-02 | 1.567 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 3.119200e-02 | 1.506 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 3.264746e-02 | 1.486 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 3.143836e-02 | 1.503 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 3.164414e-02 | 1.500 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 3.180187e-02 | 1.498 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 3.322047e-02 | 1.479 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 2.968262e-02 | 1.527 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 3.146007e-02 | 1.502 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 2.967850e-02 | 1.528 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 3.097322e-02 | 1.509 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 3.162456e-02 | 1.500 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 3.456187e-02 | 1.461 | 0 | 0 |
| IRS activation | R-HSA-74713 | 4.003042e-02 | 1.398 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 3.621031e-02 | 1.441 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 3.621031e-02 | 1.441 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 3.621031e-02 | 1.441 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 3.621031e-02 | 1.441 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 3.621031e-02 | 1.441 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 3.621031e-02 | 1.441 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 3.903160e-02 | 1.409 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 3.570282e-02 | 1.447 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 3.621031e-02 | 1.441 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 3.863364e-02 | 1.413 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 3.903160e-02 | 1.409 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 3.977955e-02 | 1.400 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 3.669460e-02 | 1.435 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 3.669460e-02 | 1.435 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 3.910531e-02 | 1.408 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 3.651526e-02 | 1.438 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 3.669460e-02 | 1.435 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 4.104818e-02 | 1.387 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 4.107474e-02 | 1.386 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 4.384740e-02 | 1.358 | 0 | 0 |
| Loss of function of TP53 in cancer due to loss of tetramerization ability | R-HSA-9723905 | 4.384740e-02 | 1.358 | 0 | 0 |
| Defective translocation of RB1 mutants to the nucleus | R-HSA-9661070 | 4.384740e-02 | 1.358 | 0 | 0 |
| Loss of Function of TP53 in Cancer | R-HSA-9723907 | 4.384740e-02 | 1.358 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 4.615573e-02 | 1.336 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 4.715882e-02 | 1.326 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 4.715882e-02 | 1.326 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 4.615573e-02 | 1.336 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 4.205653e-02 | 1.376 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 4.748293e-02 | 1.323 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 4.250357e-02 | 1.372 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 4.205653e-02 | 1.376 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 4.205653e-02 | 1.376 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 4.250357e-02 | 1.372 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 4.834534e-02 | 1.316 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 4.615573e-02 | 1.336 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 4.596752e-02 | 1.338 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 4.998892e-02 | 1.301 | 0 | 0 |
| GLI proteins bind promoters of Hh responsive genes to promote transcription | R-HSA-5635851 | 5.079184e-02 | 1.294 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 5.079184e-02 | 1.294 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 5.079184e-02 | 1.294 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 5.155623e-02 | 1.288 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 5.155623e-02 | 1.288 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 6.245523e-02 | 1.204 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 5.506612e-02 | 1.259 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 6.220665e-02 | 1.206 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 6.257746e-02 | 1.204 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 6.257746e-02 | 1.204 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 6.084961e-02 | 1.216 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 5.434741e-02 | 1.265 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 5.434741e-02 | 1.265 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 5.434741e-02 | 1.265 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 5.242286e-02 | 1.280 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 5.506612e-02 | 1.259 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 5.400359e-02 | 1.268 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 6.033343e-02 | 1.219 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 6.033343e-02 | 1.219 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 6.033343e-02 | 1.219 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 5.242286e-02 | 1.280 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 5.819986e-02 | 1.235 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 5.679678e-02 | 1.246 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 5.896347e-02 | 1.229 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 5.242286e-02 | 1.280 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 5.222427e-02 | 1.282 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 6.288504e-02 | 1.201 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 6.291643e-02 | 1.201 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 6.291643e-02 | 1.201 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 6.291643e-02 | 1.201 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 6.299970e-02 | 1.201 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 6.460777e-02 | 1.190 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 6.663874e-02 | 1.176 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 6.713576e-02 | 1.173 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 6.810062e-02 | 1.167 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 6.854629e-02 | 1.164 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 8.577476e-02 | 1.067 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 8.577476e-02 | 1.067 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 8.577476e-02 | 1.067 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 8.577476e-02 | 1.067 | 0 | 0 |
| Impaired BRCA2 binding to SEM1 (DSS1) | R-HSA-9763198 | 8.577476e-02 | 1.067 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 8.577476e-02 | 1.067 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 8.577476e-02 | 1.067 | 0 | 0 |
| Impaired BRCA2 translocation to the nucleus | R-HSA-9709275 | 8.577476e-02 | 1.067 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 7.492104e-02 | 1.125 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 6.975327e-02 | 1.156 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 8.600446e-02 | 1.065 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 7.442679e-02 | 1.128 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 8.055360e-02 | 1.094 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 8.055360e-02 | 1.094 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 7.187380e-02 | 1.143 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 7.187380e-02 | 1.143 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 7.541980e-02 | 1.123 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 8.460501e-02 | 1.073 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 8.426818e-02 | 1.074 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 7.407814e-02 | 1.130 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 7.182955e-02 | 1.144 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 8.600446e-02 | 1.065 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 7.182955e-02 | 1.144 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 8.188362e-02 | 1.087 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 7.187380e-02 | 1.143 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 7.376083e-02 | 1.132 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 8.056569e-02 | 1.094 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 8.056569e-02 | 1.094 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 8.151697e-02 | 1.089 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 7.170463e-02 | 1.144 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 7.804009e-02 | 1.108 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 7.769114e-02 | 1.110 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 6.975327e-02 | 1.156 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 7.492104e-02 | 1.125 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 8.055360e-02 | 1.094 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 8.318298e-02 | 1.080 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 8.809669e-02 | 1.055 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 8.809669e-02 | 1.055 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 1.018962e-01 | 0.992 | 0 | 0 |
| MAPK1 (ERK2) activation | R-HSA-112411 | 1.018962e-01 | 0.992 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 1.036903e-01 | 0.984 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 8.692183e-02 | 1.061 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 8.692183e-02 | 1.061 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 9.352610e-02 | 1.029 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 1.003605e-01 | 0.998 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 1.003605e-01 | 0.998 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 1.074188e-01 | 0.969 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 1.074188e-01 | 0.969 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 1.074188e-01 | 0.969 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 1.137972e-01 | 0.944 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 1.039963e-01 | 0.983 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 1.081481e-01 | 0.966 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 9.820391e-02 | 1.008 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 9.259279e-02 | 1.033 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 1.018962e-01 | 0.992 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 1.039824e-01 | 0.983 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 1.018962e-01 | 0.992 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 1.130278e-01 | 0.947 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 1.146943e-01 | 0.940 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 8.849533e-02 | 1.053 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 8.849533e-02 | 1.053 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 8.849533e-02 | 1.053 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 8.849533e-02 | 1.053 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 9.352610e-02 | 1.029 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 8.992823e-02 | 1.046 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 1.081481e-01 | 0.966 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 8.992823e-02 | 1.046 | 0 | 0 |
| M Phase | R-HSA-68886 | 1.013760e-01 | 0.994 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 1.039824e-01 | 0.983 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 9.498062e-02 | 1.022 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 9.860676e-02 | 1.006 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 8.715186e-02 | 1.060 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 9.993498e-02 | 1.000 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 1.138957e-01 | 0.943 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 8.849533e-02 | 1.053 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 9.208604e-02 | 1.036 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 8.723036e-02 | 1.059 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 9.467661e-02 | 1.024 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 1.073204e-01 | 0.969 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 9.352610e-02 | 1.029 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 1.074188e-01 | 0.969 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 9.807902e-02 | 1.008 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 1.030693e-01 | 0.987 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 1.074433e-01 | 0.969 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 1.102402e-01 | 0.958 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 1.146943e-01 | 0.940 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 9.401671e-02 | 1.027 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 1.036903e-01 | 0.984 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 1.093446e-01 | 0.961 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 1.003605e-01 | 0.998 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 1.102402e-01 | 0.958 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 1.018962e-01 | 0.992 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 9.111781e-02 | 1.040 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 9.111781e-02 | 1.040 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 1.134388e-01 | 0.945 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 1.160294e-01 | 0.935 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 1.162396e-01 | 0.935 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 1.162396e-01 | 0.935 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 1.162396e-01 | 0.935 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 1.162396e-01 | 0.935 | 0 | 0 |
| Defective VWF binding to collagen type I | R-HSA-9845622 | 1.258660e-01 | 0.900 | 0 | 0 |
| IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR) | R-HSA-5603027 | 1.258660e-01 | 0.900 | 0 | 0 |
| Defective PGM1 causes PGM1-CDG | R-HSA-5609974 | 1.258660e-01 | 0.900 | 0 | 0 |
| IKBKB deficiency causes SCID | R-HSA-5602636 | 1.258660e-01 | 0.900 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 1.642015e-01 | 0.785 | 0 | 0 |
| Stimulation of the cell death response by PAK-2p34 | R-HSA-211736 | 1.642015e-01 | 0.785 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 1.642015e-01 | 0.785 | 0 | 0 |
| Defective PAPSS2 causes SEMD-PA | R-HSA-3560796 | 1.642015e-01 | 0.785 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 1.642015e-01 | 0.785 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 1.642015e-01 | 0.785 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 1.642015e-01 | 0.785 | 0 | 0 |
| Defective VWF cleavage by ADAMTS13 variant | R-HSA-9845621 | 1.642015e-01 | 0.785 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 1.642015e-01 | 0.785 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 1.642015e-01 | 0.785 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 1.642015e-01 | 0.785 | 0 | 0 |
| Enhanced cleavage of VWF variant by ADAMTS13 | R-HSA-9845619 | 1.642015e-01 | 0.785 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 1.642015e-01 | 0.785 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 1.642015e-01 | 0.785 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 1.642015e-01 | 0.785 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 1.310529e-01 | 0.883 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 1.462675e-01 | 0.835 | 0 | 0 |
| PI3K events in ERBB4 signaling | R-HSA-1250342 | 1.462675e-01 | 0.835 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 1.618198e-01 | 0.791 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 1.618198e-01 | 0.791 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 1.618198e-01 | 0.791 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 1.226710e-01 | 0.911 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 1.326014e-01 | 0.877 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 1.532503e-01 | 0.815 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 1.221799e-01 | 0.913 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 1.298682e-01 | 0.886 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 1.540723e-01 | 0.812 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 1.624931e-01 | 0.789 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 1.352720e-01 | 0.869 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 1.661004e-01 | 0.780 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 1.445246e-01 | 0.840 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 1.748266e-01 | 0.757 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 1.388145e-01 | 0.858 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 1.298682e-01 | 0.886 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 1.326014e-01 | 0.877 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 1.226710e-01 | 0.911 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 1.326014e-01 | 0.877 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 1.415391e-01 | 0.849 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 1.661004e-01 | 0.780 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 1.618198e-01 | 0.791 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 1.527686e-01 | 0.816 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 1.349167e-01 | 0.870 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 1.295737e-01 | 0.887 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 1.326014e-01 | 0.877 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 1.639317e-01 | 0.785 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 1.639317e-01 | 0.785 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 1.748266e-01 | 0.757 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 1.710764e-01 | 0.767 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 1.285051e-01 | 0.891 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 1.532503e-01 | 0.815 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 1.662558e-01 | 0.779 | 0 | 0 |
| TGFBR3 regulates FGF2 signaling | R-HSA-9839397 | 1.258660e-01 | 0.900 | 0 | 0 |
| Inhibition of Host mRNA Processing and RNA Silencing | R-HSA-168315 | 1.258660e-01 | 0.900 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 1.462675e-01 | 0.835 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 1.618198e-01 | 0.791 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 1.428007e-01 | 0.845 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 1.377517e-01 | 0.861 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 1.287065e-01 | 0.890 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 1.723423e-01 | 0.764 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 1.637869e-01 | 0.786 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 1.540723e-01 | 0.812 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 1.261730e-01 | 0.899 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 1.536010e-01 | 0.814 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 1.618198e-01 | 0.791 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 1.494519e-01 | 0.825 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 1.710764e-01 | 0.767 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 1.551228e-01 | 0.809 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 1.285051e-01 | 0.891 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 1.310529e-01 | 0.883 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 1.326014e-01 | 0.877 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 1.748266e-01 | 0.757 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 1.540723e-01 | 0.812 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 1.300679e-01 | 0.886 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 1.639317e-01 | 0.785 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 1.256459e-01 | 0.901 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 1.349167e-01 | 0.870 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 1.669702e-01 | 0.777 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 1.462675e-01 | 0.835 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 1.624931e-01 | 0.789 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 1.624931e-01 | 0.789 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 1.710764e-01 | 0.767 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 1.536010e-01 | 0.814 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 1.497550e-01 | 0.825 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 1.618198e-01 | 0.791 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 1.618198e-01 | 0.791 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 1.618198e-01 | 0.791 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 1.326014e-01 | 0.877 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 1.458224e-01 | 0.836 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 1.441158e-01 | 0.841 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 1.532503e-01 | 0.815 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 1.532503e-01 | 0.815 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 1.680378e-01 | 0.775 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 1.547040e-01 | 0.810 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 1.662558e-01 | 0.779 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 1.226710e-01 | 0.911 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 1.699523e-01 | 0.770 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 1.428007e-01 | 0.845 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 2.008580e-01 | 0.697 | 0 | 0 |
| Adrenaline signalling through Alpha-2 adrenergic receptor | R-HSA-392023 | 2.008580e-01 | 0.697 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 2.008580e-01 | 0.697 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 2.008580e-01 | 0.697 | 0 | 0 |
| MTF1 activates gene expression | R-HSA-5660489 | 2.359090e-01 | 0.627 | 0 | 0 |
| HCN channels | R-HSA-1296061 | 2.359090e-01 | 0.627 | 0 | 0 |
| Nucleotide catabolism defects | R-HSA-9735786 | 2.359090e-01 | 0.627 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 2.359090e-01 | 0.627 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 2.359090e-01 | 0.627 | 0 | 0 |
| Defective PNP disrupts phosphorolysis of (deoxy)guanosine and (deoxy)inosine | R-HSA-9735763 | 2.359090e-01 | 0.627 | 0 | 0 |
| FBXW7 Mutants and NOTCH1 in Cancer | R-HSA-2644605 | 2.359090e-01 | 0.627 | 0 | 0 |
| Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling | R-HSA-2644607 | 2.359090e-01 | 0.627 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 2.694246e-01 | 0.570 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 2.694246e-01 | 0.570 | 0 | 0 |
| Enhanced binding of GP1BA variant to VWF multimer:collagen | R-HSA-9845620 | 2.694246e-01 | 0.570 | 0 | 0 |
| Defective binding of VWF variant to GPIb:IX:V | R-HSA-9846298 | 2.694246e-01 | 0.570 | 0 | 0 |
| Defects of platelet adhesion to exposed collagen | R-HSA-9823587 | 3.014720e-01 | 0.521 | 0 | 0 |
| Nef Mediated CD8 Down-regulation | R-HSA-182218 | 3.014720e-01 | 0.521 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 3.014720e-01 | 0.521 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 3.014720e-01 | 0.521 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 3.014720e-01 | 0.521 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 3.014720e-01 | 0.521 | 0 | 0 |
| Signaling by MAPK mutants | R-HSA-9652817 | 3.014720e-01 | 0.521 | 0 | 0 |
| Signaling by RNF43 mutants | R-HSA-5340588 | 3.014720e-01 | 0.521 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 1.776511e-01 | 0.750 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 1.776511e-01 | 0.750 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 1.776511e-01 | 0.750 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 1.776511e-01 | 0.750 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 3.321156e-01 | 0.479 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 3.321156e-01 | 0.479 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 2.099376e-01 | 0.678 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 2.099376e-01 | 0.678 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 2.592347e-01 | 0.586 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 2.757387e-01 | 0.560 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 2.757387e-01 | 0.560 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 2.757387e-01 | 0.560 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 2.086118e-01 | 0.681 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 2.086118e-01 | 0.681 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 3.086533e-01 | 0.511 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 2.436828e-01 | 0.613 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 2.836167e-01 | 0.547 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 2.653525e-01 | 0.576 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 3.523841e-01 | 0.453 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 3.429651e-01 | 0.465 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 2.620831e-01 | 0.582 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 3.342148e-01 | 0.476 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 1.775736e-01 | 0.751 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 3.250069e-01 | 0.488 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 3.250069e-01 | 0.488 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 2.592347e-01 | 0.586 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 2.592347e-01 | 0.586 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 3.235066e-01 | 0.490 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 1.776511e-01 | 0.750 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 3.086533e-01 | 0.511 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 3.432565e-01 | 0.464 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 2.637065e-01 | 0.579 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 3.281036e-01 | 0.484 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 2.427421e-01 | 0.615 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 2.427421e-01 | 0.615 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 2.082834e-01 | 0.681 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 2.427421e-01 | 0.615 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 2.201819e-01 | 0.657 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 3.094068e-01 | 0.509 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 2.555814e-01 | 0.592 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 2.099376e-01 | 0.678 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 2.427421e-01 | 0.615 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 2.262968e-01 | 0.645 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 2.349870e-01 | 0.629 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 2.694246e-01 | 0.570 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 2.099376e-01 | 0.678 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 2.262968e-01 | 0.645 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 2.922215e-01 | 0.534 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 2.161301e-01 | 0.665 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 3.038079e-01 | 0.517 | 0 | 0 |
| Transcriptional activation of cell cycle inhibitor p21 | R-HSA-69895 | 2.359090e-01 | 0.627 | 0 | 0 |
| Transcriptional activation of p53 responsive genes | R-HSA-69560 | 2.359090e-01 | 0.627 | 0 | 0 |
| SARS-CoV-1-mediated effects on programmed cell death | R-HSA-9692913 | 2.359090e-01 | 0.627 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 2.099376e-01 | 0.678 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 2.592347e-01 | 0.586 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 3.159516e-01 | 0.500 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 2.712051e-01 | 0.567 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 2.339210e-01 | 0.631 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 1.937070e-01 | 0.713 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 2.427537e-01 | 0.615 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 3.175249e-01 | 0.498 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 2.555814e-01 | 0.592 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 2.262968e-01 | 0.645 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 2.836167e-01 | 0.547 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 2.637065e-01 | 0.579 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 2.702245e-01 | 0.568 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 2.008580e-01 | 0.697 | 0 | 0 |
| Trafficking of myristoylated proteins to the cilium | R-HSA-5624138 | 2.694246e-01 | 0.570 | 0 | 0 |
| Reelin signalling pathway | R-HSA-8866376 | 2.694246e-01 | 0.570 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 3.014720e-01 | 0.521 | 0 | 0 |
| Sensory perception of salty taste | R-HSA-9730628 | 3.014720e-01 | 0.521 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 2.757387e-01 | 0.560 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 2.161301e-01 | 0.665 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 2.003837e-01 | 0.698 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 3.536740e-01 | 0.451 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 1.771554e-01 | 0.752 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 2.068633e-01 | 0.684 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 2.068633e-01 | 0.684 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 2.147773e-01 | 0.668 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 2.239396e-01 | 0.650 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 2.201819e-01 | 0.657 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 3.086533e-01 | 0.511 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 3.302169e-01 | 0.481 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 2.318777e-01 | 0.635 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 1.798137e-01 | 0.745 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 2.368820e-01 | 0.625 | 0 | 0 |
| Activation of NOXA and translocation to mitochondria | R-HSA-111448 | 2.359090e-01 | 0.627 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 2.262968e-01 | 0.645 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 3.038079e-01 | 0.517 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 1.818054e-01 | 0.740 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 2.081997e-01 | 0.682 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 2.961206e-01 | 0.529 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 2.068633e-01 | 0.684 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 2.680604e-01 | 0.572 | 0 | 0 |
| Prolactin receptor signaling | R-HSA-1170546 | 1.937070e-01 | 0.713 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 3.523841e-01 | 0.453 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 3.523841e-01 | 0.453 | 0 | 0 |
| p75NTR negatively regulates cell cycle via SC1 | R-HSA-193670 | 2.359090e-01 | 0.627 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 2.359090e-01 | 0.627 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 1.937070e-01 | 0.713 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 3.321156e-01 | 0.479 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 2.592347e-01 | 0.586 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 1.977158e-01 | 0.704 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 3.250069e-01 | 0.488 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 2.059799e-01 | 0.686 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 3.536740e-01 | 0.451 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 3.536740e-01 | 0.451 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 2.817041e-01 | 0.550 | 0 | 0 |
| Histamine receptors | R-HSA-390650 | 2.008580e-01 | 0.697 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 3.321156e-01 | 0.479 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 2.555814e-01 | 0.592 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 2.081997e-01 | 0.682 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 3.235066e-01 | 0.490 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 2.477944e-01 | 0.606 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 2.757387e-01 | 0.560 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 2.161301e-01 | 0.665 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 2.161301e-01 | 0.665 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 2.445599e-01 | 0.612 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 2.145921e-01 | 0.668 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 2.436828e-01 | 0.613 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 2.569634e-01 | 0.590 | 0 | 0 |
| S Phase | R-HSA-69242 | 3.298011e-01 | 0.482 | 0 | 0 |
| Relaxin receptors | R-HSA-444821 | 3.014720e-01 | 0.521 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 1.776511e-01 | 0.750 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 3.321156e-01 | 0.479 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 2.086118e-01 | 0.681 | 0 | 0 |
| Synthesis, secretion, and deacylation of Ghrelin | R-HSA-422085 | 3.250069e-01 | 0.488 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 2.795973e-01 | 0.553 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 3.250069e-01 | 0.488 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 2.994636e-01 | 0.524 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 2.261926e-01 | 0.646 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 1.776511e-01 | 0.750 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 2.795973e-01 | 0.553 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 2.161135e-01 | 0.665 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 3.159516e-01 | 0.500 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 2.945143e-01 | 0.531 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 2.321603e-01 | 0.634 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 2.694246e-01 | 0.570 | 0 | 0 |
| Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660826 | 3.014720e-01 | 0.521 | 0 | 0 |
| Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660825 | 3.014720e-01 | 0.521 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 3.321156e-01 | 0.479 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 2.255075e-01 | 0.647 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 2.077703e-01 | 0.682 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 2.477944e-01 | 0.606 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 2.477944e-01 | 0.606 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 3.402517e-01 | 0.468 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 2.318777e-01 | 0.635 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 2.099376e-01 | 0.678 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 2.555814e-01 | 0.592 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 3.081041e-01 | 0.511 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 2.339210e-01 | 0.631 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 2.627806e-01 | 0.580 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 3.014720e-01 | 0.521 | 0 | 0 |
| SLC15A4:TASL-dependent IRF5 activation | R-HSA-9860276 | 3.014720e-01 | 0.521 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 1.937070e-01 | 0.713 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 2.262968e-01 | 0.645 | 0 | 0 |
| Creatine metabolism | R-HSA-71288 | 3.086533e-01 | 0.511 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 2.503843e-01 | 0.601 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 3.536740e-01 | 0.451 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 3.028373e-01 | 0.519 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 2.694246e-01 | 0.570 | 0 | 0 |
| TYSND1 cleaves peroxisomal proteins | R-HSA-9033500 | 3.014720e-01 | 0.521 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 2.099376e-01 | 0.678 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 1.776511e-01 | 0.750 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 3.235066e-01 | 0.490 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 1.926706e-01 | 0.715 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 3.250069e-01 | 0.488 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 1.856176e-01 | 0.731 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 1.776511e-01 | 0.750 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 3.402517e-01 | 0.468 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 2.129395e-01 | 0.672 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 2.592347e-01 | 0.586 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 1.937070e-01 | 0.713 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 2.836167e-01 | 0.547 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 3.094068e-01 | 0.509 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 2.922215e-01 | 0.534 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 1.790136e-01 | 0.747 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 3.573831e-01 | 0.447 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 3.614166e-01 | 0.442 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to limit cholesterol uptake | R-HSA-9031525 | 3.614166e-01 | 0.442 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose | R-HSA-9031528 | 3.614166e-01 | 0.442 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to gluconeogenesis | R-HSA-9632974 | 3.614166e-01 | 0.442 | 0 | 0 |
| Nef Mediated CD4 Down-regulation | R-HSA-167590 | 3.614166e-01 | 0.442 | 0 | 0 |
| Microbial modulation of RIPK1-mediated regulated necrosis | R-HSA-9686347 | 3.614166e-01 | 0.442 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 3.614166e-01 | 0.442 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 3.614166e-01 | 0.442 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 3.614166e-01 | 0.442 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 3.614166e-01 | 0.442 | 0 | 0 |
| TGFBR3 regulates TGF-beta signaling | R-HSA-9839389 | 3.614166e-01 | 0.442 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 3.644895e-01 | 0.438 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 3.692890e-01 | 0.433 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 3.705249e-01 | 0.431 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 3.716932e-01 | 0.430 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 3.720678e-01 | 0.429 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 3.726611e-01 | 0.429 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 3.733139e-01 | 0.428 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 3.737975e-01 | 0.427 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 3.753364e-01 | 0.426 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 3.758757e-01 | 0.425 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 3.765572e-01 | 0.424 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 3.765572e-01 | 0.424 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 3.765572e-01 | 0.424 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 3.838429e-01 | 0.416 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 3.858991e-01 | 0.414 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 3.885772e-01 | 0.411 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 3.885772e-01 | 0.411 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 3.885772e-01 | 0.411 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 3.891790e-01 | 0.410 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 3.891790e-01 | 0.410 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 3.891790e-01 | 0.410 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 3.891790e-01 | 0.410 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 3.894338e-01 | 0.410 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 3.894338e-01 | 0.410 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 3.894338e-01 | 0.410 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 3.894338e-01 | 0.410 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 3.894338e-01 | 0.410 | 0 | 0 |
| FGFR1b ligand binding and activation | R-HSA-190370 | 3.894338e-01 | 0.410 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 3.894338e-01 | 0.410 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 3.941911e-01 | 0.404 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 3.957483e-01 | 0.403 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 3.957483e-01 | 0.403 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 4.005398e-01 | 0.397 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 4.005398e-01 | 0.397 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 4.162234e-01 | 0.381 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 4.162234e-01 | 0.381 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 4.162234e-01 | 0.381 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 4.162234e-01 | 0.381 | 0 | 0 |
| Regulation of signaling by NODAL | R-HSA-1433617 | 4.162234e-01 | 0.381 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 4.162234e-01 | 0.381 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 4.162234e-01 | 0.381 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 4.162234e-01 | 0.381 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 4.162234e-01 | 0.381 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 4.166834e-01 | 0.380 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 4.202561e-01 | 0.376 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 4.202561e-01 | 0.376 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 4.202561e-01 | 0.376 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 4.202561e-01 | 0.376 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 4.202561e-01 | 0.376 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 4.202561e-01 | 0.376 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 4.280671e-01 | 0.368 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 4.305667e-01 | 0.366 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 4.354895e-01 | 0.361 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 4.354895e-01 | 0.361 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 4.359949e-01 | 0.361 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 4.359949e-01 | 0.361 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 4.362352e-01 | 0.360 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 4.418392e-01 | 0.355 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 4.418392e-01 | 0.355 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 4.418392e-01 | 0.355 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 4.418392e-01 | 0.355 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 4.418392e-01 | 0.355 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 4.418392e-01 | 0.355 | 0 | 0 |
| Interleukin-27 signaling | R-HSA-9020956 | 4.418392e-01 | 0.355 | 0 | 0 |
| Defective RIPK1-mediated regulated necrosis | R-HSA-9693928 | 4.418392e-01 | 0.355 | 0 | 0 |
| Cross-presentation of particulate exogenous antigens (phagosomes) | R-HSA-1236973 | 4.418392e-01 | 0.355 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 4.418392e-01 | 0.355 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 4.418392e-01 | 0.355 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 4.435062e-01 | 0.353 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 4.498162e-01 | 0.347 | 0 | 0 |
| Pyrimidine salvage | R-HSA-73614 | 4.505037e-01 | 0.346 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 4.526527e-01 | 0.344 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 4.591913e-01 | 0.338 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 4.591913e-01 | 0.338 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 4.630314e-01 | 0.334 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 4.630314e-01 | 0.334 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 4.652887e-01 | 0.332 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 4.652887e-01 | 0.332 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 4.652887e-01 | 0.332 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 4.663324e-01 | 0.331 | 0 | 0 |
| Regulation of gene expression in early pancreatic precursor cells | R-HSA-210747 | 4.663324e-01 | 0.331 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 4.663324e-01 | 0.331 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 4.669720e-01 | 0.331 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 4.671891e-01 | 0.331 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 4.727040e-01 | 0.325 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 4.792989e-01 | 0.319 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 4.798355e-01 | 0.319 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 4.798355e-01 | 0.319 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 4.798355e-01 | 0.319 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 4.811146e-01 | 0.318 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 4.816554e-01 | 0.317 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 4.819702e-01 | 0.317 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 4.823107e-01 | 0.317 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 4.823107e-01 | 0.317 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 4.823107e-01 | 0.317 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 4.897523e-01 | 0.310 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 4.897523e-01 | 0.310 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 4.897523e-01 | 0.310 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by WNT ligand antagonists | R-HSA-3772470 | 4.897523e-01 | 0.310 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 4.897523e-01 | 0.310 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 4.897523e-01 | 0.310 | 0 | 0 |
| Plasmalogen biosynthesis | R-HSA-75896 | 4.897523e-01 | 0.310 | 0 | 0 |
| Anchoring fibril formation | R-HSA-2214320 | 4.897523e-01 | 0.310 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 4.897523e-01 | 0.310 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 4.918474e-01 | 0.308 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 4.941367e-01 | 0.306 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 4.941367e-01 | 0.306 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 5.009219e-01 | 0.300 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 5.013103e-01 | 0.300 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 5.106956e-01 | 0.292 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 5.121457e-01 | 0.291 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 5.121457e-01 | 0.291 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 5.121457e-01 | 0.291 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 5.121457e-01 | 0.291 | 0 | 0 |
| Interleukin-35 Signalling | R-HSA-8984722 | 5.121457e-01 | 0.291 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 5.121457e-01 | 0.291 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 5.121457e-01 | 0.291 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 5.121457e-01 | 0.291 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 5.121457e-01 | 0.291 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 5.121457e-01 | 0.291 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 5.121457e-01 | 0.291 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 5.152530e-01 | 0.288 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 5.152530e-01 | 0.288 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 5.219775e-01 | 0.282 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 5.219775e-01 | 0.282 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 5.219775e-01 | 0.282 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 5.219775e-01 | 0.282 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 5.219775e-01 | 0.282 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 5.219775e-01 | 0.282 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 5.260533e-01 | 0.279 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 5.260910e-01 | 0.279 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 5.319309e-01 | 0.274 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 5.335576e-01 | 0.273 | 0 | 0 |
| Adenylate cyclase activating pathway | R-HSA-170660 | 5.335576e-01 | 0.273 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 5.335576e-01 | 0.273 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 5.335576e-01 | 0.273 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 5.335576e-01 | 0.273 | 0 | 0 |
| Diseases of nucleotide metabolism | R-HSA-9735804 | 5.335576e-01 | 0.273 | 0 | 0 |
| FGFR1c ligand binding and activation | R-HSA-190373 | 5.335576e-01 | 0.273 | 0 | 0 |
| IL-6-type cytokine receptor ligand interactions | R-HSA-6788467 | 5.335576e-01 | 0.273 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 5.335576e-01 | 0.273 | 0 | 0 |
| RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | R-HSA-8877330 | 5.335576e-01 | 0.273 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 5.343888e-01 | 0.272 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 5.343888e-01 | 0.272 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 5.383522e-01 | 0.269 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 5.383522e-01 | 0.269 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 5.473944e-01 | 0.262 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 5.473944e-01 | 0.262 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 5.487714e-01 | 0.261 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 5.487714e-01 | 0.261 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 5.487714e-01 | 0.261 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 5.501127e-01 | 0.260 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 5.540311e-01 | 0.256 | 0 | 0 |
| cGMP effects | R-HSA-418457 | 5.540311e-01 | 0.256 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 5.540311e-01 | 0.256 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 5.540311e-01 | 0.256 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 5.540311e-01 | 0.256 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 5.540311e-01 | 0.256 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 5.540311e-01 | 0.256 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 5.540311e-01 | 0.256 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 5.540311e-01 | 0.256 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 5.540311e-01 | 0.256 | 0 | 0 |
| Malate-aspartate shuttle | R-HSA-9856872 | 5.540311e-01 | 0.256 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 5.540311e-01 | 0.256 | 0 | 0 |
| P2Y receptors | R-HSA-417957 | 5.540311e-01 | 0.256 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 5.563434e-01 | 0.255 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 5.566236e-01 | 0.254 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 5.576752e-01 | 0.254 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 5.577787e-01 | 0.254 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 5.617673e-01 | 0.250 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 5.617673e-01 | 0.250 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 5.634868e-01 | 0.249 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 5.736070e-01 | 0.241 | 0 | 0 |
| Adenylate cyclase inhibitory pathway | R-HSA-170670 | 5.736070e-01 | 0.241 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 5.736070e-01 | 0.241 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 5.736070e-01 | 0.241 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 5.736070e-01 | 0.241 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 5.736070e-01 | 0.241 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 5.736070e-01 | 0.241 | 0 | 0 |
| Transport and metabolism of PAPS | R-HSA-174362 | 5.736070e-01 | 0.241 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 5.736070e-01 | 0.241 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 5.736070e-01 | 0.241 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 5.736070e-01 | 0.241 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 5.736070e-01 | 0.241 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 5.736070e-01 | 0.241 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 5.739524e-01 | 0.241 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 5.781820e-01 | 0.238 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 5.781820e-01 | 0.238 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 5.826077e-01 | 0.235 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 5.869470e-01 | 0.231 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 5.869470e-01 | 0.231 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 5.869470e-01 | 0.231 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 5.911609e-01 | 0.228 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 5.911609e-01 | 0.228 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 5.923249e-01 | 0.227 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 5.923249e-01 | 0.227 | 0 | 0 |
| Entry of Influenza Virion into Host Cell via Endocytosis | R-HSA-168275 | 5.923249e-01 | 0.227 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 5.923249e-01 | 0.227 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 5.923249e-01 | 0.227 | 0 | 0 |
| Regulation of BACH1 activity | R-HSA-9708530 | 5.923249e-01 | 0.227 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 5.923249e-01 | 0.227 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 5.923249e-01 | 0.227 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 5.923249e-01 | 0.227 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 5.979831e-01 | 0.223 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 5.979831e-01 | 0.223 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 5.979831e-01 | 0.223 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 5.991288e-01 | 0.222 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 5.995941e-01 | 0.222 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 6.076528e-01 | 0.216 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 6.079535e-01 | 0.216 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 6.102221e-01 | 0.215 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 6.102221e-01 | 0.215 | 0 | 0 |
| Passive transport by Aquaporins | R-HSA-432047 | 6.102221e-01 | 0.215 | 0 | 0 |
| Fibronectin matrix formation | R-HSA-1566977 | 6.102221e-01 | 0.215 | 0 | 0 |
| Galactose catabolism | R-HSA-70370 | 6.102221e-01 | 0.215 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) | R-HSA-400511 | 6.102221e-01 | 0.215 | 0 | 0 |
| Response to metal ions | R-HSA-5660526 | 6.102221e-01 | 0.215 | 0 | 0 |
| tRNA modification in the mitochondrion | R-HSA-6787450 | 6.102221e-01 | 0.215 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 6.110382e-01 | 0.214 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 6.161898e-01 | 0.210 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 6.171664e-01 | 0.210 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 6.171664e-01 | 0.210 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 6.171664e-01 | 0.210 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 6.226757e-01 | 0.206 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 6.226757e-01 | 0.206 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 6.226757e-01 | 0.206 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 6.226757e-01 | 0.206 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 6.226757e-01 | 0.206 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 6.243175e-01 | 0.205 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 6.243697e-01 | 0.205 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 6.265226e-01 | 0.203 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 6.265226e-01 | 0.203 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 6.265226e-01 | 0.203 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 6.273347e-01 | 0.203 | 0 | 0 |
| Metabolism of ingested H2SeO4 and H2SeO3 into H2Se | R-HSA-2408550 | 6.273347e-01 | 0.203 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 6.273347e-01 | 0.203 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 6.273677e-01 | 0.202 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 6.323353e-01 | 0.199 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 6.334580e-01 | 0.198 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 6.340421e-01 | 0.198 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 6.340421e-01 | 0.198 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 6.340421e-01 | 0.198 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 6.357205e-01 | 0.197 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 6.357205e-01 | 0.197 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 6.397122e-01 | 0.194 | 0 | 0 |
| Nephron development | R-HSA-9831926 | 6.436969e-01 | 0.191 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 6.436969e-01 | 0.191 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 6.436969e-01 | 0.191 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 6.436969e-01 | 0.191 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 6.436969e-01 | 0.191 | 0 | 0 |
| FGFR1 ligand binding and activation | R-HSA-190242 | 6.436969e-01 | 0.191 | 0 | 0 |
| PKA activation | R-HSA-163615 | 6.436969e-01 | 0.191 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 6.436969e-01 | 0.191 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 6.436969e-01 | 0.191 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 6.436969e-01 | 0.191 | 0 | 0 |
| Nucleotide-like (purinergic) receptors | R-HSA-418038 | 6.436969e-01 | 0.191 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 6.447592e-01 | 0.191 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 6.450389e-01 | 0.190 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 6.451389e-01 | 0.190 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 6.451389e-01 | 0.190 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 6.451389e-01 | 0.190 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 6.454674e-01 | 0.190 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 6.480373e-01 | 0.188 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 6.536382e-01 | 0.185 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 6.559678e-01 | 0.183 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 6.572439e-01 | 0.182 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 6.593417e-01 | 0.181 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 6.593417e-01 | 0.181 | 0 | 0 |
| Crosslinking of collagen fibrils | R-HSA-2243919 | 6.593417e-01 | 0.181 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 6.593417e-01 | 0.181 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 6.593417e-01 | 0.181 | 0 | 0 |
| Diseases of hemostasis | R-HSA-9671793 | 6.593417e-01 | 0.181 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 6.593417e-01 | 0.181 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 6.662478e-01 | 0.176 | 0 | 0 |
| Synthesis of very long-chain fatty acyl-CoAs | R-HSA-75876 | 6.665309e-01 | 0.176 | 0 | 0 |
| Protein folding | R-HSA-391251 | 6.707439e-01 | 0.173 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 6.707439e-01 | 0.173 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 6.743005e-01 | 0.171 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 6.743005e-01 | 0.171 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 6.743005e-01 | 0.171 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 6.743005e-01 | 0.171 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 6.743005e-01 | 0.171 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 6.743005e-01 | 0.171 | 0 | 0 |
| Wax and plasmalogen biosynthesis | R-HSA-8848584 | 6.743005e-01 | 0.171 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 6.743005e-01 | 0.171 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 6.743005e-01 | 0.171 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 6.743005e-01 | 0.171 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 6.743005e-01 | 0.171 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 6.743005e-01 | 0.171 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 6.743005e-01 | 0.171 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 6.768307e-01 | 0.170 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 6.768307e-01 | 0.170 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 6.793145e-01 | 0.168 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 6.795088e-01 | 0.168 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 6.822298e-01 | 0.166 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 6.868699e-01 | 0.163 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 6.868699e-01 | 0.163 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 6.881691e-01 | 0.162 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 6.886033e-01 | 0.162 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 6.886033e-01 | 0.162 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 6.886033e-01 | 0.162 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 6.886033e-01 | 0.162 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 6.886033e-01 | 0.162 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 6.886033e-01 | 0.162 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 6.886033e-01 | 0.162 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 6.928731e-01 | 0.159 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 6.966516e-01 | 0.157 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 6.966516e-01 | 0.157 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 6.971182e-01 | 0.157 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 7.022788e-01 | 0.153 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 7.022788e-01 | 0.153 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 7.022788e-01 | 0.153 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 7.022788e-01 | 0.153 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 7.022788e-01 | 0.153 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 7.022788e-01 | 0.153 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 7.022788e-01 | 0.153 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 7.022788e-01 | 0.153 | 0 | 0 |
| Ribavirin ADME | R-HSA-9755088 | 7.022788e-01 | 0.153 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 7.049583e-01 | 0.152 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 7.055458e-01 | 0.151 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 7.055458e-01 | 0.151 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 7.055458e-01 | 0.151 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 7.061790e-01 | 0.151 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 7.062991e-01 | 0.151 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 7.111900e-01 | 0.148 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 7.153546e-01 | 0.145 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 7.153546e-01 | 0.145 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 7.153546e-01 | 0.145 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 7.153546e-01 | 0.145 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 7.153546e-01 | 0.145 | 0 | 0 |
| Ethanol oxidation | R-HSA-71384 | 7.153546e-01 | 0.145 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 7.154555e-01 | 0.145 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 7.244848e-01 | 0.140 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 7.244848e-01 | 0.140 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 7.244848e-01 | 0.140 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 7.252644e-01 | 0.140 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 7.263670e-01 | 0.139 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 7.278568e-01 | 0.138 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 7.278568e-01 | 0.138 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 7.278568e-01 | 0.138 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 7.278568e-01 | 0.138 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 7.332707e-01 | 0.135 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 7.341900e-01 | 0.134 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 7.398106e-01 | 0.131 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 7.398106e-01 | 0.131 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 7.398106e-01 | 0.131 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 7.398106e-01 | 0.131 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 7.401145e-01 | 0.131 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 7.418172e-01 | 0.130 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 7.418172e-01 | 0.130 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 7.451804e-01 | 0.128 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 7.501283e-01 | 0.125 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 7.512401e-01 | 0.124 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 7.512401e-01 | 0.124 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 7.512401e-01 | 0.124 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 7.512401e-01 | 0.124 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 7.512401e-01 | 0.124 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 7.512401e-01 | 0.124 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 7.546190e-01 | 0.122 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 7.548681e-01 | 0.122 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 7.572342e-01 | 0.121 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 7.582082e-01 | 0.120 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 7.613038e-01 | 0.118 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 7.621681e-01 | 0.118 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 7.621681e-01 | 0.118 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 7.621681e-01 | 0.118 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 7.621681e-01 | 0.118 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 7.621681e-01 | 0.118 | 0 | 0 |
| Synthesis of IP2, IP, and Ins in the cytosol | R-HSA-1855183 | 7.621681e-01 | 0.118 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 7.622776e-01 | 0.118 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 7.630938e-01 | 0.117 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 7.688428e-01 | 0.114 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 7.726167e-01 | 0.112 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 7.726167e-01 | 0.112 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 7.726167e-01 | 0.112 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 7.726167e-01 | 0.112 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 7.726167e-01 | 0.112 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 7.726167e-01 | 0.112 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 7.726167e-01 | 0.112 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 7.736916e-01 | 0.111 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 7.804753e-01 | 0.108 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 7.811038e-01 | 0.107 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 7.811038e-01 | 0.107 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 7.811038e-01 | 0.107 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 7.826069e-01 | 0.106 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 7.826069e-01 | 0.106 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 7.826069e-01 | 0.106 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 7.854350e-01 | 0.105 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 7.854350e-01 | 0.105 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 7.907506e-01 | 0.102 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 7.921587e-01 | 0.101 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 7.921587e-01 | 0.101 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 7.921587e-01 | 0.101 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 7.925383e-01 | 0.101 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 7.925383e-01 | 0.101 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 7.952914e-01 | 0.099 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 7.971267e-01 | 0.098 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 8.001068e-01 | 0.097 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 8.012915e-01 | 0.096 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 8.020757e-01 | 0.096 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 8.040445e-01 | 0.095 | 0 | 0 |
| Kinesins | R-HSA-983189 | 8.086597e-01 | 0.092 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 8.086597e-01 | 0.092 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 8.100234e-01 | 0.092 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 8.100234e-01 | 0.092 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 8.100234e-01 | 0.092 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 8.100234e-01 | 0.092 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 8.100234e-01 | 0.092 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 8.100234e-01 | 0.092 | 0 | 0 |
| Aspartate and asparagine metabolism | R-HSA-8963693 | 8.100234e-01 | 0.092 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 8.149949e-01 | 0.089 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 8.150096e-01 | 0.089 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 8.150478e-01 | 0.089 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 8.150478e-01 | 0.089 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 8.150478e-01 | 0.089 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 8.157609e-01 | 0.088 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 8.157923e-01 | 0.088 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 8.183721e-01 | 0.087 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 8.202944e-01 | 0.086 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 8.202944e-01 | 0.086 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 8.263545e-01 | 0.083 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 8.263545e-01 | 0.083 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 8.263545e-01 | 0.083 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 8.263545e-01 | 0.083 | 0 | 0 |
| Diseases associated with glycosylation precursor biosynthesis | R-HSA-5609975 | 8.263545e-01 | 0.083 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 8.267014e-01 | 0.083 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 8.272546e-01 | 0.082 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 8.272546e-01 | 0.082 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 8.339864e-01 | 0.079 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 8.339864e-01 | 0.079 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 8.339864e-01 | 0.079 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 8.339864e-01 | 0.079 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 8.339864e-01 | 0.079 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 8.339864e-01 | 0.079 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 8.339864e-01 | 0.079 | 0 | 0 |
| Glutamate and glutamine metabolism | R-HSA-8964539 | 8.339864e-01 | 0.079 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 8.353829e-01 | 0.078 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 8.401643e-01 | 0.076 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 8.401643e-01 | 0.076 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 8.412834e-01 | 0.075 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 8.412834e-01 | 0.075 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 8.412834e-01 | 0.075 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 8.412834e-01 | 0.075 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 8.412834e-01 | 0.075 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 8.412834e-01 | 0.075 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 8.412834e-01 | 0.075 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 8.448252e-01 | 0.073 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 8.482601e-01 | 0.071 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 8.482601e-01 | 0.071 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 8.482601e-01 | 0.071 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 8.482601e-01 | 0.071 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 8.482601e-01 | 0.071 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 8.482601e-01 | 0.071 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 8.493678e-01 | 0.071 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 8.495140e-01 | 0.071 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 8.499980e-01 | 0.071 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 8.533754e-01 | 0.069 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 8.537942e-01 | 0.069 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 8.545702e-01 | 0.068 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 8.546556e-01 | 0.068 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 8.546556e-01 | 0.068 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 8.549305e-01 | 0.068 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 8.549305e-01 | 0.068 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 8.549305e-01 | 0.068 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 8.549305e-01 | 0.068 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 8.549305e-01 | 0.068 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 8.549305e-01 | 0.068 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 8.549305e-01 | 0.068 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 8.613081e-01 | 0.065 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 8.613081e-01 | 0.065 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 8.613081e-01 | 0.065 | 0 | 0 |
| Beta-oxidation of very long chain fatty acids | R-HSA-390247 | 8.613081e-01 | 0.065 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 8.623076e-01 | 0.064 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 8.631356e-01 | 0.064 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 8.644606e-01 | 0.063 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 8.644606e-01 | 0.063 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 8.663987e-01 | 0.062 | 0 | 0 |
| Depurination | R-HSA-73927 | 8.674057e-01 | 0.062 | 0 | 0 |
| Purine salvage | R-HSA-74217 | 8.674057e-01 | 0.062 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 8.674057e-01 | 0.062 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 8.691324e-01 | 0.061 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 8.698527e-01 | 0.061 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 8.732355e-01 | 0.059 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 8.732355e-01 | 0.059 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 8.732355e-01 | 0.059 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 8.732355e-01 | 0.059 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 8.742611e-01 | 0.058 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 8.779162e-01 | 0.057 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 8.780349e-01 | 0.056 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 8.780349e-01 | 0.056 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 8.788094e-01 | 0.056 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 8.788094e-01 | 0.056 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 8.788094e-01 | 0.056 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 8.788094e-01 | 0.056 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 8.809657e-01 | 0.055 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 8.809657e-01 | 0.055 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 8.822736e-01 | 0.054 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 8.841385e-01 | 0.053 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 8.841385e-01 | 0.053 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 8.863757e-01 | 0.052 | 0 | 0 |
| Disease | R-HSA-1643685 | 8.887769e-01 | 0.051 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 8.892335e-01 | 0.051 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 8.892335e-01 | 0.051 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 8.892335e-01 | 0.051 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 8.941049e-01 | 0.049 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 8.941049e-01 | 0.049 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 8.941049e-01 | 0.049 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 8.941049e-01 | 0.049 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 8.941049e-01 | 0.049 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 8.941049e-01 | 0.049 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 8.979004e-01 | 0.047 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 8.979004e-01 | 0.047 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 8.987622e-01 | 0.046 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 8.987622e-01 | 0.046 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 8.987622e-01 | 0.046 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 9.014936e-01 | 0.045 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 9.032150e-01 | 0.044 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 9.032150e-01 | 0.044 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 9.032150e-01 | 0.044 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 9.049686e-01 | 0.043 | 0 | 0 |
| Translation | R-HSA-72766 | 9.049783e-01 | 0.043 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 9.051460e-01 | 0.043 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 9.074722e-01 | 0.042 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 9.074722e-01 | 0.042 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 9.074722e-01 | 0.042 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 9.074722e-01 | 0.042 | 0 | 0 |
| Diseases associated with glycosaminoglycan metabolism | R-HSA-3560782 | 9.074722e-01 | 0.042 | 0 | 0 |
| Degradation of cysteine and homocysteine | R-HSA-1614558 | 9.074722e-01 | 0.042 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 9.074722e-01 | 0.042 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 9.077234e-01 | 0.042 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 9.102960e-01 | 0.041 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 9.115424e-01 | 0.040 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 9.151690e-01 | 0.038 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 9.191543e-01 | 0.037 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 9.191543e-01 | 0.037 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 9.191543e-01 | 0.037 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 9.206879e-01 | 0.036 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 9.227112e-01 | 0.035 | 0 | 0 |
| Glyoxylate metabolism and glycine degradation | R-HSA-389661 | 9.227112e-01 | 0.035 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 9.235232e-01 | 0.035 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 9.261119e-01 | 0.033 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 9.261119e-01 | 0.033 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 9.293632e-01 | 0.032 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 9.324643e-01 | 0.030 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 9.324715e-01 | 0.030 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 9.324715e-01 | 0.030 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 9.354433e-01 | 0.029 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 9.354433e-01 | 0.029 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 9.354433e-01 | 0.029 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 9.382845e-01 | 0.028 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.410008e-01 | 0.026 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 9.410824e-01 | 0.026 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.410824e-01 | 0.026 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 9.431325e-01 | 0.025 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 9.434172e-01 | 0.025 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 9.435977e-01 | 0.025 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 9.435977e-01 | 0.025 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.460804e-01 | 0.024 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 9.484540e-01 | 0.023 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 9.492280e-01 | 0.023 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.507233e-01 | 0.022 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 9.526674e-01 | 0.021 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 9.528928e-01 | 0.021 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.528928e-01 | 0.021 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 9.528928e-01 | 0.021 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 9.532534e-01 | 0.021 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 9.549668e-01 | 0.020 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 9.560790e-01 | 0.020 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 9.569497e-01 | 0.019 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 9.569497e-01 | 0.019 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 9.597723e-01 | 0.018 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 9.597723e-01 | 0.018 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 9.607447e-01 | 0.017 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.616943e-01 | 0.017 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 9.627370e-01 | 0.016 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 9.656304e-01 | 0.015 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 9.656304e-01 | 0.015 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.656304e-01 | 0.015 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 9.660418e-01 | 0.015 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 9.679666e-01 | 0.014 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 9.698906e-01 | 0.013 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.712980e-01 | 0.013 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 9.712980e-01 | 0.013 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 9.712980e-01 | 0.013 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 9.725626e-01 | 0.012 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 9.731435e-01 | 0.012 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.749273e-01 | 0.011 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.751208e-01 | 0.011 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 9.760322e-01 | 0.011 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 9.760322e-01 | 0.011 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.794680e-01 | 0.009 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.809924e-01 | 0.008 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 9.813749e-01 | 0.008 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 9.832889e-01 | 0.007 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.833705e-01 | 0.007 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 9.836534e-01 | 0.007 | 0 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 9.840257e-01 | 0.007 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 9.859083e-01 | 0.006 | 0 | 0 |
| Sulfur amino acid metabolism | R-HSA-1614635 | 9.860471e-01 | 0.006 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.860471e-01 | 0.006 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.877982e-01 | 0.005 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 9.883506e-01 | 0.005 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 9.898094e-01 | 0.004 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 9.902021e-01 | 0.004 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.911315e-01 | 0.004 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 9.918806e-01 | 0.004 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 9.918806e-01 | 0.004 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 9.919545e-01 | 0.004 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 9.925815e-01 | 0.003 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.929090e-01 | 0.003 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.931112e-01 | 0.003 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 9.932220e-01 | 0.003 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 9.935212e-01 | 0.003 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 9.943420e-01 | 0.002 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.943694e-01 | 0.002 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 9.950039e-01 | 0.002 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 9.950589e-01 | 0.002 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.952126e-01 | 0.002 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 9.953874e-01 | 0.002 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 9.955681e-01 | 0.002 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.958757e-01 | 0.002 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.960579e-01 | 0.002 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 9.960766e-01 | 0.002 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 9.967097e-01 | 0.001 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 9.976568e-01 | 0.001 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.977891e-01 | 0.001 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.979990e-01 | 0.001 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 9.980041e-01 | 0.001 | 0 | 0 |
| Regulation of Complement cascade | R-HSA-977606 | 9.980874e-01 | 0.001 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 9.981086e-01 | 0.001 | 0 | 0 |
| Immune System | R-HSA-168256 | 9.981810e-01 | 0.001 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 9.982285e-01 | 0.001 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.982528e-01 | 0.001 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 9.984746e-01 | 0.001 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 9.986682e-01 | 0.001 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 9.988933e-01 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.989251e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.990095e-01 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.992221e-01 | 0.000 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 9.992256e-01 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.992391e-01 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.992677e-01 | 0.000 | 0 | 0 |
| Complement cascade | R-HSA-166658 | 9.993546e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.994341e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.994654e-01 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.994854e-01 | 0.000 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 9.994870e-01 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.995078e-01 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 9.995300e-01 | 0.000 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.995567e-01 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 9.996886e-01 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.997465e-01 | 0.000 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.998267e-01 | 0.000 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.998267e-01 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.998397e-01 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 9.999301e-01 | 0.000 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.999461e-01 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.999630e-01 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.999916e-01 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 9.999947e-01 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 9.999970e-01 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 9.999986e-01 | 0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 9.999986e-01 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.999992e-01 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.999994e-01 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 9.999997e-01 | 0.000 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 1.000000e+00 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 1.000000e+00 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| HSF1-dependent transactivation | R-HSA-3371571 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 1.110223e-16 | 15.955 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 2.220446e-16 | 15.654 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 1.776357e-15 | 14.750 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 1.132427e-14 | 13.946 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 3.753664e-13 | 12.426 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 1.975531e-12 | 11.704 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 6.165779e-11 | 10.210 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 1.367227e-10 | 9.864 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 3.919394e-10 | 9.407 | 0 | 0 |
| M Phase | R-HSA-68886 | 5.192963e-09 | 8.285 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 3.818071e-08 | 7.418 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 4.137777e-08 | 7.383 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 6.474223e-08 | 7.189 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 6.644716e-08 | 7.178 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 7.092610e-08 | 7.149 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 8.291733e-08 | 7.081 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 1.949959e-07 | 6.710 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 2.475227e-07 | 6.606 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 5.732264e-07 | 6.242 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 6.635420e-07 | 6.178 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 7.982353e-07 | 6.098 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 1.026814e-06 | 5.989 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 1.149603e-06 | 5.939 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 1.104291e-06 | 5.957 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 1.183578e-06 | 5.927 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 1.608915e-06 | 5.793 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 1.859251e-06 | 5.731 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 2.557074e-06 | 5.592 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 3.525906e-06 | 5.453 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 3.668269e-06 | 5.436 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 3.999737e-06 | 5.398 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 4.182061e-06 | 5.379 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 5.794334e-06 | 5.237 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 6.487292e-06 | 5.188 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 7.523624e-06 | 5.124 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 1.131735e-05 | 4.946 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 1.184443e-05 | 4.926 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 1.261088e-05 | 4.899 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 1.229130e-05 | 4.910 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 1.312167e-05 | 4.882 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 1.773272e-05 | 4.751 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 1.756430e-05 | 4.755 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 1.844685e-05 | 4.734 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 1.934236e-05 | 4.713 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 2.033029e-05 | 4.692 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 2.280709e-05 | 4.642 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 4.763499e-05 | 4.322 | 0 | 0 |
| Kinesins | R-HSA-983189 | 5.050823e-05 | 4.297 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 5.522713e-05 | 4.258 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 6.052129e-05 | 4.218 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 6.224672e-05 | 4.206 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 8.344913e-05 | 4.079 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 8.344913e-05 | 4.079 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 8.628755e-05 | 4.064 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 8.418055e-05 | 4.075 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 1.286578e-04 | 3.891 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 1.351112e-04 | 3.869 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 1.548109e-04 | 3.810 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 1.548109e-04 | 3.810 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 1.725996e-04 | 3.763 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 1.844486e-04 | 3.734 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 2.490586e-04 | 3.604 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 2.496653e-04 | 3.603 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 2.548799e-04 | 3.594 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 2.846137e-04 | 3.546 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 2.846137e-04 | 3.546 | 0 | 0 |
| Protein folding | R-HSA-391251 | 3.341395e-04 | 3.476 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 3.400650e-04 | 3.468 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 3.688381e-04 | 3.433 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 4.019885e-04 | 3.396 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 4.183447e-04 | 3.378 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 4.371181e-04 | 3.359 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 4.910762e-04 | 3.309 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 4.910762e-04 | 3.309 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 4.702037e-04 | 3.328 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 5.032231e-04 | 3.298 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 5.554675e-04 | 3.255 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 6.166057e-04 | 3.210 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 6.263879e-04 | 3.203 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 8.965669e-04 | 3.047 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 9.489725e-04 | 3.023 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 9.744878e-04 | 3.011 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 9.744878e-04 | 3.011 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 1.017722e-03 | 2.992 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 1.024500e-03 | 2.989 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 1.125182e-03 | 2.949 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 1.177281e-03 | 2.929 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 1.241358e-03 | 2.906 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 1.269660e-03 | 2.896 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 1.269660e-03 | 2.896 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 1.269660e-03 | 2.896 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 1.269660e-03 | 2.896 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 1.366667e-03 | 2.864 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 1.366667e-03 | 2.864 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 1.366667e-03 | 2.864 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 1.366667e-03 | 2.864 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 1.307577e-03 | 2.884 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 1.451296e-03 | 2.838 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 1.484373e-03 | 2.828 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 1.509770e-03 | 2.821 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 1.555121e-03 | 2.808 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 1.573881e-03 | 2.803 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 1.591636e-03 | 2.798 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 1.794731e-03 | 2.746 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 1.842634e-03 | 2.735 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 1.842634e-03 | 2.735 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 1.842634e-03 | 2.735 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 1.943187e-03 | 2.711 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 2.154246e-03 | 2.667 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 2.066148e-03 | 2.685 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 2.177665e-03 | 2.662 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 2.208688e-03 | 2.656 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 2.429817e-03 | 2.614 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 2.429817e-03 | 2.614 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 2.429817e-03 | 2.614 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 2.429817e-03 | 2.614 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 2.429817e-03 | 2.614 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 2.429817e-03 | 2.614 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 2.377717e-03 | 2.624 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 2.383607e-03 | 2.623 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 2.594193e-03 | 2.586 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 2.626974e-03 | 2.581 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 2.711871e-03 | 2.567 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 2.889876e-03 | 2.539 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 3.142247e-03 | 2.503 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 3.402039e-03 | 2.468 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 3.402039e-03 | 2.468 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 3.389853e-03 | 2.470 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 3.628500e-03 | 2.440 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 3.657137e-03 | 2.437 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 3.657137e-03 | 2.437 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 3.829922e-03 | 2.417 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 3.860274e-03 | 2.413 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 4.106714e-03 | 2.387 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 4.175866e-03 | 2.379 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 4.340607e-03 | 2.362 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 4.380024e-03 | 2.359 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 4.399200e-03 | 2.357 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 4.420558e-03 | 2.355 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 4.464042e-03 | 2.350 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 4.913931e-03 | 2.309 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 4.591009e-03 | 2.338 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 4.971322e-03 | 2.304 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 4.999214e-03 | 2.301 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 4.999214e-03 | 2.301 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 5.114392e-03 | 2.291 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 5.185920e-03 | 2.285 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 5.192203e-03 | 2.285 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 5.207481e-03 | 2.283 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 5.230658e-03 | 2.281 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 5.370074e-03 | 2.270 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 5.423291e-03 | 2.266 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 5.423291e-03 | 2.266 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 5.619498e-03 | 2.250 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 5.831762e-03 | 2.234 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 5.831936e-03 | 2.234 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 5.946095e-03 | 2.226 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 6.893334e-03 | 2.162 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 6.136998e-03 | 2.212 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 6.869052e-03 | 2.163 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 6.415415e-03 | 2.193 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 7.201291e-03 | 2.143 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 7.663171e-03 | 2.116 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 7.663171e-03 | 2.116 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 8.240690e-03 | 2.084 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 8.708954e-03 | 2.060 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 8.723565e-03 | 2.059 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 8.830341e-03 | 2.054 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 8.864872e-03 | 2.052 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 9.498119e-03 | 2.022 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 9.498119e-03 | 2.022 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 1.115176e-02 | 1.953 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 1.011699e-02 | 1.995 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 1.082310e-02 | 1.966 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 1.082310e-02 | 1.966 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 1.082310e-02 | 1.966 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 1.082515e-02 | 1.966 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 1.082515e-02 | 1.966 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 1.116151e-02 | 1.952 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 1.118906e-02 | 1.951 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 1.133690e-02 | 1.946 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 1.153407e-02 | 1.938 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 1.221368e-02 | 1.913 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 1.237191e-02 | 1.908 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 1.237191e-02 | 1.908 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 1.256115e-02 | 1.901 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 1.279671e-02 | 1.893 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 1.337592e-02 | 1.874 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 1.342536e-02 | 1.872 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 1.386301e-02 | 1.858 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 1.386301e-02 | 1.858 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 1.499764e-02 | 1.824 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 1.499764e-02 | 1.824 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 1.560564e-02 | 1.807 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 1.529014e-02 | 1.816 | 0 | 0 |
| S Phase | R-HSA-69242 | 1.618024e-02 | 1.791 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 1.604528e-02 | 1.795 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 1.615495e-02 | 1.792 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 1.401762e-02 | 1.853 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 1.591885e-02 | 1.798 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 1.594348e-02 | 1.797 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 1.629357e-02 | 1.788 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 1.658417e-02 | 1.780 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 1.691080e-02 | 1.772 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 1.813798e-02 | 1.741 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 1.930958e-02 | 1.714 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 1.994308e-02 | 1.700 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 2.005135e-02 | 1.698 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 2.012820e-02 | 1.696 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 2.034662e-02 | 1.692 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 2.041021e-02 | 1.690 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 2.221273e-02 | 1.653 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 2.221273e-02 | 1.653 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 2.221273e-02 | 1.653 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 2.221273e-02 | 1.653 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 2.221273e-02 | 1.653 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 2.221273e-02 | 1.653 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 2.221273e-02 | 1.653 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 2.221273e-02 | 1.653 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 2.221273e-02 | 1.653 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 2.221273e-02 | 1.653 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 2.221273e-02 | 1.653 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 2.561187e-02 | 1.592 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 2.561187e-02 | 1.592 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 2.286811e-02 | 1.641 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 2.417730e-02 | 1.617 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 2.358033e-02 | 1.627 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 2.551741e-02 | 1.593 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 2.561187e-02 | 1.592 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 2.286811e-02 | 1.641 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 2.139622e-02 | 1.670 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 2.187821e-02 | 1.660 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 2.358033e-02 | 1.627 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 2.294156e-02 | 1.639 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 2.551741e-02 | 1.593 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 2.537707e-02 | 1.596 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 2.551741e-02 | 1.593 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 2.465824e-02 | 1.608 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 2.234955e-02 | 1.651 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 2.561187e-02 | 1.592 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 2.591319e-02 | 1.586 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 2.811957e-02 | 1.551 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 2.842622e-02 | 1.546 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 2.842622e-02 | 1.546 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 2.954610e-02 | 1.529 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 2.965897e-02 | 1.528 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 2.977459e-02 | 1.526 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 3.086881e-02 | 1.510 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 3.191416e-02 | 1.496 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 3.191416e-02 | 1.496 | 0 | 0 |
| Butyrophilin (BTN) family interactions | R-HSA-8851680 | 3.191416e-02 | 1.496 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 3.207673e-02 | 1.494 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 3.223608e-02 | 1.492 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 3.229722e-02 | 1.491 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 3.272229e-02 | 1.485 | 0 | 0 |
| Signaling by FGFR1 amplification mutants | R-HSA-1839120 | 3.344706e-02 | 1.476 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 3.426324e-02 | 1.465 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 3.466419e-02 | 1.460 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 3.466419e-02 | 1.460 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 3.466419e-02 | 1.460 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 3.483100e-02 | 1.458 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 3.543510e-02 | 1.451 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 3.680871e-02 | 1.434 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 3.681409e-02 | 1.434 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 3.708747e-02 | 1.431 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 4.642331e-02 | 1.333 | 0 | 0 |
| Drug-mediated inhibition of CDK4/CDK6 activity | R-HSA-9754119 | 4.642331e-02 | 1.333 | 0 | 0 |
| TGFBR1 KD Mutants in Cancer | R-HSA-3656532 | 4.642331e-02 | 1.333 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 4.180302e-02 | 1.379 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 4.180302e-02 | 1.379 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 4.618162e-02 | 1.336 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 4.477151e-02 | 1.349 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 4.569463e-02 | 1.340 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 4.366521e-02 | 1.360 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 3.894965e-02 | 1.409 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 4.642331e-02 | 1.333 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 3.812713e-02 | 1.419 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 4.561594e-02 | 1.341 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 4.653737e-02 | 1.332 | 0 | 0 |
| Activation of NOXA and translocation to mitochondria | R-HSA-111448 | 4.642331e-02 | 1.333 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 4.200186e-02 | 1.377 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 3.735233e-02 | 1.428 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 4.308413e-02 | 1.366 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 4.191610e-02 | 1.378 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 4.671264e-02 | 1.331 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 4.713733e-02 | 1.327 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 4.794348e-02 | 1.319 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 4.814434e-02 | 1.317 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 4.922817e-02 | 1.308 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 4.980423e-02 | 1.303 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 5.067061e-02 | 1.295 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 5.144940e-02 | 1.289 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 5.320902e-02 | 1.274 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 5.322164e-02 | 1.274 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 5.322164e-02 | 1.274 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 5.380294e-02 | 1.269 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 5.380294e-02 | 1.269 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 5.413354e-02 | 1.267 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 5.437760e-02 | 1.265 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 5.515553e-02 | 1.258 | 0 | 0 |
| Deletions in the AMER1 gene destabilize the destruction complex | R-HSA-5467343 | 5.523917e-02 | 1.258 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 5.523917e-02 | 1.258 | 0 | 0 |
| Defective translocation of RB1 mutants to the nucleus | R-HSA-9661070 | 5.523917e-02 | 1.258 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 5.592751e-02 | 1.252 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 5.592751e-02 | 1.252 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 5.624952e-02 | 1.250 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 5.665293e-02 | 1.247 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 5.817308e-02 | 1.235 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 5.868376e-02 | 1.231 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 6.000838e-02 | 1.222 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 6.091520e-02 | 1.215 | 0 | 0 |
| IRS activation | R-HSA-74713 | 6.091520e-02 | 1.215 | 0 | 0 |
| G2 Phase | R-HSA-68911 | 6.091520e-02 | 1.215 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 6.091520e-02 | 1.215 | 0 | 0 |
| SMAD2/3 Phosphorylation Motif Mutants in Cancer | R-HSA-3304356 | 6.091520e-02 | 1.215 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in invasion | R-HSA-9854909 | 6.091520e-02 | 1.215 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 6.214777e-02 | 1.207 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 6.214777e-02 | 1.207 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 6.262116e-02 | 1.203 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 6.318016e-02 | 1.199 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 6.345556e-02 | 1.198 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 6.345556e-02 | 1.198 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 6.428124e-02 | 1.192 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 6.757748e-02 | 1.170 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 6.793283e-02 | 1.168 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 6.984657e-02 | 1.156 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 6.984657e-02 | 1.156 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 6.995571e-02 | 1.155 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 7.671605e-02 | 1.115 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 7.741128e-02 | 1.111 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 7.400610e-02 | 1.131 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 7.400610e-02 | 1.131 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 8.036474e-02 | 1.095 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 8.036474e-02 | 1.095 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 9.112410e-02 | 1.040 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 9.112410e-02 | 1.040 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 7.593457e-02 | 1.120 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 9.363740e-02 | 1.029 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 7.593457e-02 | 1.120 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 9.363740e-02 | 1.029 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 7.741128e-02 | 1.111 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 7.593457e-02 | 1.120 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 7.366397e-02 | 1.133 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 8.988498e-02 | 1.046 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 7.405245e-02 | 1.130 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 7.122675e-02 | 1.147 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 8.858087e-02 | 1.053 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 8.234683e-02 | 1.084 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 7.400610e-02 | 1.131 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 9.363740e-02 | 1.029 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 8.036474e-02 | 1.095 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 9.062557e-02 | 1.043 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 8.060499e-02 | 1.094 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 7.222036e-02 | 1.141 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 8.988498e-02 | 1.046 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 7.671605e-02 | 1.115 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 9.062557e-02 | 1.043 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 9.363740e-02 | 1.029 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 7.400610e-02 | 1.131 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 8.700508e-02 | 1.060 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 8.539803e-02 | 1.069 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 8.216885e-02 | 1.085 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 7.405172e-02 | 1.130 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 7.262898e-02 | 1.139 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 9.370504e-02 | 1.028 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 9.392269e-02 | 1.027 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 9.392269e-02 | 1.027 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 9.540484e-02 | 1.020 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 9.540484e-02 | 1.020 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 9.540484e-02 | 1.020 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 9.540484e-02 | 1.020 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 9.624899e-02 | 1.017 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 9.671228e-02 | 1.015 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 1.074301e-01 | 0.969 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 1.074301e-01 | 0.969 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 1.074301e-01 | 0.969 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 1.074301e-01 | 0.969 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 1.074301e-01 | 0.969 | 0 | 0 |
| PP2A-mediated dephosphorylation of key metabolic factors | R-HSA-163767 | 1.115075e-01 | 0.953 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 1.115075e-01 | 0.953 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 1.115075e-01 | 0.953 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 1.115075e-01 | 0.953 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 1.301703e-01 | 0.885 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 1.301703e-01 | 0.885 | 0 | 0 |
| FGFR1b ligand binding and activation | R-HSA-190370 | 1.301703e-01 | 0.885 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 1.301703e-01 | 0.885 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 1.494838e-01 | 0.825 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 1.494838e-01 | 0.825 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 1.494838e-01 | 0.825 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 1.069176e-01 | 0.971 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 1.069176e-01 | 0.971 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 1.189400e-01 | 0.925 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 1.314349e-01 | 0.881 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 1.314349e-01 | 0.881 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 1.314349e-01 | 0.881 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 1.443647e-01 | 0.841 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 1.443647e-01 | 0.841 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 1.024116e-01 | 0.990 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 1.024116e-01 | 0.990 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 1.208795e-01 | 0.918 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 1.208795e-01 | 0.918 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 1.306120e-01 | 0.884 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 1.306120e-01 | 0.884 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 1.406564e-01 | 0.852 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 1.302585e-01 | 0.885 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 1.375624e-01 | 0.862 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 1.375624e-01 | 0.862 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 1.494838e-01 | 0.825 | 0 | 0 |
| FGFR1 ligand binding and activation | R-HSA-190242 | 1.443647e-01 | 0.841 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 1.494838e-01 | 0.825 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 1.349088e-01 | 0.870 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 1.301703e-01 | 0.885 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 1.494838e-01 | 0.825 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 1.212416e-01 | 0.916 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 1.011124e-01 | 0.995 | 0 | 0 |
| Fibronectin matrix formation | R-HSA-1566977 | 1.189400e-01 | 0.925 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 1.024116e-01 | 0.990 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 1.375624e-01 | 0.862 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 1.162323e-01 | 0.935 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 1.242525e-01 | 0.906 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 1.189400e-01 | 0.925 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 1.314349e-01 | 0.881 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 1.454087e-01 | 0.837 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 1.427974e-01 | 0.845 | 0 | 0 |
| Formation of editosomes by ADAR proteins | R-HSA-77042 | 1.074301e-01 | 0.969 | 0 | 0 |
| Inhibition of PKR | R-HSA-169131 | 1.074301e-01 | 0.969 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 1.069176e-01 | 0.971 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 1.443647e-01 | 0.841 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 1.324658e-01 | 0.878 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 1.443647e-01 | 0.841 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 9.975641e-02 | 1.001 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 1.227193e-01 | 0.911 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 1.085684e-01 | 0.964 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 1.409161e-01 | 0.851 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 1.115075e-01 | 0.953 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 1.115075e-01 | 0.953 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 9.975641e-02 | 1.001 | 0 | 0 |
| TGFBR3 regulates TGF-beta signaling | R-HSA-9839389 | 1.115075e-01 | 0.953 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 1.021291e-01 | 0.991 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 1.375624e-01 | 0.862 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 1.427974e-01 | 0.845 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 1.369178e-01 | 0.864 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 1.114744e-01 | 0.953 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 1.314349e-01 | 0.881 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 1.364492e-01 | 0.865 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 1.301703e-01 | 0.885 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 1.306120e-01 | 0.884 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 1.459381e-01 | 0.836 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 1.298937e-01 | 0.886 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 1.115075e-01 | 0.953 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 1.494838e-01 | 0.825 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 1.494838e-01 | 0.825 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 1.242525e-01 | 0.906 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 1.324658e-01 | 0.878 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 1.071837e-01 | 0.970 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 1.138222e-01 | 0.944 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 1.409161e-01 | 0.851 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 1.115075e-01 | 0.953 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 1.494838e-01 | 0.825 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 1.162841e-01 | 0.934 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 1.135081e-01 | 0.945 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 1.012335e-01 | 0.995 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 1.012208e-01 | 0.995 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 1.508121e-01 | 0.822 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 1.509967e-01 | 0.821 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 1.509967e-01 | 0.821 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 1.516926e-01 | 0.819 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 1.538260e-01 | 0.813 | 0 | 0 |
| Interactions of Tat with host cellular proteins | R-HSA-176034 | 1.567409e-01 | 0.805 | 0 | 0 |
| SMAD4 MH2 Domain Mutants in Cancer | R-HSA-3311021 | 1.567409e-01 | 0.805 | 0 | 0 |
| SMAD2/3 MH2 Domain Mutants in Cancer | R-HSA-3315487 | 1.567409e-01 | 0.805 | 0 | 0 |
| Loss of Function of SMAD4 in Cancer | R-HSA-3304347 | 1.567409e-01 | 0.805 | 0 | 0 |
| TGFBR3 regulates FGF2 signaling | R-HSA-9839397 | 1.567409e-01 | 0.805 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 1.567409e-01 | 0.805 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 1.567409e-01 | 0.805 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 1.576210e-01 | 0.802 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 1.576918e-01 | 0.802 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 1.576918e-01 | 0.802 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 1.598718e-01 | 0.796 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 1.598718e-01 | 0.796 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 1.605752e-01 | 0.794 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 1.605752e-01 | 0.794 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 1.605752e-01 | 0.794 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 1.676001e-01 | 0.776 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 1.678029e-01 | 0.775 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 1.685943e-01 | 0.773 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 1.685943e-01 | 0.773 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 1.693194e-01 | 0.771 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 1.693194e-01 | 0.771 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 1.693194e-01 | 0.771 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 1.693194e-01 | 0.771 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 1.693194e-01 | 0.771 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 1.693194e-01 | 0.771 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 1.693194e-01 | 0.771 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 1.693194e-01 | 0.771 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 1.696724e-01 | 0.770 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 1.713785e-01 | 0.766 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 1.713785e-01 | 0.766 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 1.713785e-01 | 0.766 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 1.724976e-01 | 0.763 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 1.727059e-01 | 0.763 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 1.734107e-01 | 0.761 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 1.743818e-01 | 0.758 | 0 | 0 |
| TGFBR1 LBD Mutants in Cancer | R-HSA-3656535 | 2.033303e-01 | 0.692 | 0 | 0 |
| TGFBR2 Kinase Domain Mutants in Cancer | R-HSA-3645790 | 2.033303e-01 | 0.692 | 0 | 0 |
| Signaling by plasma membrane FGFR1 fusions | R-HSA-8853336 | 2.473483e-01 | 0.607 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 2.473483e-01 | 0.607 | 0 | 0 |
| Signaling by MAP2K mutants | R-HSA-9652169 | 2.889367e-01 | 0.539 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 2.889367e-01 | 0.539 | 0 | 0 |
| FGFR1c and Klotho ligand binding and activation | R-HSA-190374 | 3.282295e-01 | 0.484 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 3.282295e-01 | 0.484 | 0 | 0 |
| Defective F9 activation | R-HSA-9673221 | 3.282295e-01 | 0.484 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 3.282295e-01 | 0.484 | 0 | 0 |
| Enhanced binding of GP1BA variant to VWF multimer:collagen | R-HSA-9845620 | 3.282295e-01 | 0.484 | 0 | 0 |
| Defective binding of VWF variant to GPIb:IX:V | R-HSA-9846298 | 3.282295e-01 | 0.484 | 0 | 0 |
| Signaling by activated point mutants of FGFR1 | R-HSA-1839122 | 2.101024e-01 | 0.678 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 2.308498e-01 | 0.637 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 2.308498e-01 | 0.637 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 2.517177e-01 | 0.599 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 2.517177e-01 | 0.599 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 1.853877e-01 | 0.732 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 1.853877e-01 | 0.732 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 1.996829e-01 | 0.700 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 2.726293e-01 | 0.564 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 2.142285e-01 | 0.669 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 2.935164e-01 | 0.532 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 2.935164e-01 | 0.532 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 1.949774e-01 | 0.710 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 3.143178e-01 | 0.503 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 3.143178e-01 | 0.503 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 3.143178e-01 | 0.503 | 0 | 0 |
| Phospholipase C-mediated cascade: FGFR1 | R-HSA-5654219 | 3.554532e-01 | 0.449 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 2.159389e-01 | 0.666 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 2.668830e-01 | 0.574 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 3.202778e-01 | 0.494 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 2.793355e-01 | 0.554 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 2.793355e-01 | 0.554 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 2.793355e-01 | 0.554 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 2.679840e-01 | 0.572 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 3.171605e-01 | 0.499 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 3.004327e-01 | 0.522 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 3.047071e-01 | 0.516 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 3.445334e-01 | 0.463 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 3.510492e-01 | 0.455 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 2.742342e-01 | 0.562 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 3.048889e-01 | 0.516 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 3.202778e-01 | 0.494 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 1.836239e-01 | 0.736 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 2.022460e-01 | 0.694 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 3.048889e-01 | 0.516 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 2.049906e-01 | 0.688 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 2.423106e-01 | 0.616 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 1.864061e-01 | 0.730 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 3.243589e-01 | 0.489 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 3.154080e-01 | 0.501 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 2.889367e-01 | 0.539 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 3.282295e-01 | 0.484 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 2.308498e-01 | 0.637 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 2.517177e-01 | 0.599 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 2.895319e-01 | 0.538 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 3.245539e-01 | 0.489 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 3.130163e-01 | 0.504 | 0 | 0 |
| Formation of the posterior neural plate | R-HSA-9832991 | 1.895606e-01 | 0.722 | 0 | 0 |
| Activation of AKT2 | R-HSA-165158 | 3.282295e-01 | 0.484 | 0 | 0 |
| PTK6 Down-Regulation | R-HSA-8849472 | 3.282295e-01 | 0.484 | 0 | 0 |
| FGFR1c ligand binding and activation | R-HSA-190373 | 2.517177e-01 | 0.599 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 3.554532e-01 | 0.449 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 3.044902e-01 | 0.516 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 2.573428e-01 | 0.589 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 2.542736e-01 | 0.595 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 2.065406e-01 | 0.685 | 0 | 0 |
| Inhibition of nitric oxide production | R-HSA-9636249 | 2.473483e-01 | 0.607 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 3.282295e-01 | 0.484 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 2.935164e-01 | 0.532 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 3.143178e-01 | 0.503 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 2.289494e-01 | 0.640 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 1.936100e-01 | 0.713 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 1.936100e-01 | 0.713 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 1.936100e-01 | 0.713 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 1.936100e-01 | 0.713 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 2.321594e-01 | 0.634 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 2.101024e-01 | 0.678 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 2.110193e-01 | 0.676 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 3.223977e-01 | 0.492 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 2.380917e-01 | 0.623 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 2.354983e-01 | 0.628 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 2.289494e-01 | 0.640 | 0 | 0 |
| mRNA Editing: A to I Conversion | R-HSA-75064 | 2.033303e-01 | 0.692 | 0 | 0 |
| C6 deamination of adenosine | R-HSA-75102 | 2.033303e-01 | 0.692 | 0 | 0 |
| Loss of Function of TGFBR2 in Cancer | R-HSA-3642278 | 2.033303e-01 | 0.692 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 2.033303e-01 | 0.692 | 0 | 0 |
| STAT6-mediated induction of chemokines | R-HSA-3249367 | 2.473483e-01 | 0.607 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 2.473483e-01 | 0.607 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 2.889367e-01 | 0.539 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 2.101024e-01 | 0.678 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 2.308498e-01 | 0.637 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 2.517177e-01 | 0.599 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 3.143178e-01 | 0.503 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 3.349794e-01 | 0.475 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 1.864061e-01 | 0.730 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 2.022460e-01 | 0.694 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 1.818423e-01 | 0.740 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 2.573428e-01 | 0.589 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 2.918766e-01 | 0.535 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 3.356728e-01 | 0.474 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 1.984606e-01 | 0.702 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 3.298721e-01 | 0.482 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 2.742342e-01 | 0.562 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 2.279110e-01 | 0.642 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 2.590243e-01 | 0.587 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 3.553600e-01 | 0.449 | 0 | 0 |
| Translation | R-HSA-72766 | 2.116338e-01 | 0.674 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 3.048889e-01 | 0.516 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 2.961947e-01 | 0.528 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 2.119115e-01 | 0.674 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 3.349794e-01 | 0.475 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 1.957984e-01 | 0.708 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 2.914919e-01 | 0.535 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 3.202778e-01 | 0.494 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 2.065406e-01 | 0.685 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 1.787985e-01 | 0.748 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 1.895606e-01 | 0.722 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 2.935164e-01 | 0.532 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 3.334492e-01 | 0.477 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 3.333585e-01 | 0.477 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 2.036136e-01 | 0.691 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 3.456601e-01 | 0.461 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 3.202778e-01 | 0.494 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 2.199228e-01 | 0.658 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 1.901244e-01 | 0.721 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 3.342512e-01 | 0.476 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 3.456601e-01 | 0.461 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 2.384913e-01 | 0.623 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 1.918744e-01 | 0.717 | 0 | 0 |
| Intracellular oxygen transport | R-HSA-8981607 | 2.473483e-01 | 0.607 | 0 | 0 |
| p75NTR negatively regulates cell cycle via SC1 | R-HSA-193670 | 2.889367e-01 | 0.539 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 3.282295e-01 | 0.484 | 0 | 0 |
| Inositol transporters | R-HSA-429593 | 3.282295e-01 | 0.484 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 2.935164e-01 | 0.532 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 1.836239e-01 | 0.736 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 3.349794e-01 | 0.475 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 3.279935e-01 | 0.484 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 3.426101e-01 | 0.465 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 1.936100e-01 | 0.713 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 2.679840e-01 | 0.572 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 3.553600e-01 | 0.449 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 2.515696e-01 | 0.599 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 3.356728e-01 | 0.474 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 3.530106e-01 | 0.452 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 3.572559e-01 | 0.447 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 2.110193e-01 | 0.676 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 2.637965e-01 | 0.579 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 3.047071e-01 | 0.516 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 3.320477e-01 | 0.479 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 2.688798e-01 | 0.570 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 3.282295e-01 | 0.484 | 0 | 0 |
| Phosphorylation and nuclear translocation of BMAL1 (ARNTL) and CLOCK | R-HSA-9931529 | 3.282295e-01 | 0.484 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 3.282295e-01 | 0.484 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 2.101024e-01 | 0.678 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 2.517177e-01 | 0.599 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 3.202778e-01 | 0.494 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 2.159389e-01 | 0.666 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 2.793355e-01 | 0.554 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 2.291864e-01 | 0.640 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 3.243589e-01 | 0.489 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 2.935164e-01 | 0.532 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 3.554532e-01 | 0.449 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 1.879400e-01 | 0.726 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 3.356728e-01 | 0.474 | 0 | 0 |
| Immune System | R-HSA-168256 | 3.348270e-01 | 0.475 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 2.123099e-01 | 0.673 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 2.092783e-01 | 0.679 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 2.092783e-01 | 0.679 | 0 | 0 |
| ATF6B (ATF6-beta) activates chaperones | R-HSA-8874177 | 2.033303e-01 | 0.692 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 2.517177e-01 | 0.599 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 2.935164e-01 | 0.532 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 3.554532e-01 | 0.449 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 2.907838e-01 | 0.536 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 2.826826e-01 | 0.549 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 2.826826e-01 | 0.549 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 2.826826e-01 | 0.549 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 3.409613e-01 | 0.467 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 1.836239e-01 | 0.736 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 3.143178e-01 | 0.503 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 3.572559e-01 | 0.447 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 1.895606e-01 | 0.722 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 2.521176e-01 | 0.598 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 2.101024e-01 | 0.678 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 2.289895e-01 | 0.640 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 2.742342e-01 | 0.562 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 2.918766e-01 | 0.535 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 2.573428e-01 | 0.589 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 2.258133e-01 | 0.646 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 3.143178e-01 | 0.503 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 2.065406e-01 | 0.685 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 2.521176e-01 | 0.598 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 2.133568e-01 | 0.671 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 3.556406e-01 | 0.449 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 3.036371e-01 | 0.518 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 2.770246e-01 | 0.557 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 2.564420e-01 | 0.591 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 2.668830e-01 | 0.574 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 3.608629e-01 | 0.443 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 3.614314e-01 | 0.442 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 3.653532e-01 | 0.437 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 3.653532e-01 | 0.437 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 3.653532e-01 | 0.437 | 0 | 0 |
| Signaling by MAPK mutants | R-HSA-9652817 | 3.653532e-01 | 0.437 | 0 | 0 |
| CLEC7A/inflammasome pathway | R-HSA-5660668 | 3.653532e-01 | 0.437 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 3.653532e-01 | 0.437 | 0 | 0 |
| Synthesis of PS | R-HSA-1483101 | 3.653532e-01 | 0.437 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 3.653532e-01 | 0.437 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 3.653532e-01 | 0.437 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 3.653532e-01 | 0.437 | 0 | 0 |
| Defects of platelet adhesion to exposed collagen | R-HSA-9823587 | 3.653532e-01 | 0.437 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 3.653532e-01 | 0.437 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 3.653532e-01 | 0.437 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 3.653532e-01 | 0.437 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 3.653532e-01 | 0.437 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 3.657079e-01 | 0.437 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 3.681080e-01 | 0.434 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 3.693486e-01 | 0.433 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 3.693486e-01 | 0.433 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 3.741775e-01 | 0.427 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 3.741775e-01 | 0.427 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 3.756969e-01 | 0.425 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 3.756969e-01 | 0.425 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 3.756969e-01 | 0.425 | 0 | 0 |
| Nephron development | R-HSA-9831926 | 3.756969e-01 | 0.425 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 3.756969e-01 | 0.425 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 3.772823e-01 | 0.423 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 3.808406e-01 | 0.419 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 3.813510e-01 | 0.419 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 3.813510e-01 | 0.419 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 3.816559e-01 | 0.418 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 3.826606e-01 | 0.417 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 3.840935e-01 | 0.416 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 3.935450e-01 | 0.405 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 3.935450e-01 | 0.405 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 3.956734e-01 | 0.403 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 3.956734e-01 | 0.403 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 3.956734e-01 | 0.403 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 3.956734e-01 | 0.403 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 3.956734e-01 | 0.403 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 4.004275e-01 | 0.397 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 4.004275e-01 | 0.397 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 4.004275e-01 | 0.397 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 4.004275e-01 | 0.397 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 4.004275e-01 | 0.397 | 0 | 0 |
| VLDL assembly | R-HSA-8866423 | 4.004275e-01 | 0.397 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 4.062089e-01 | 0.391 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 4.096553e-01 | 0.388 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 4.098967e-01 | 0.387 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 4.119298e-01 | 0.385 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 4.119298e-01 | 0.385 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 4.119298e-01 | 0.385 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 4.153505e-01 | 0.382 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 4.153505e-01 | 0.382 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 4.166459e-01 | 0.380 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 4.170806e-01 | 0.380 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 4.222538e-01 | 0.374 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 4.240215e-01 | 0.373 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 4.241851e-01 | 0.372 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 4.247013e-01 | 0.372 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 4.268954e-01 | 0.370 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 4.313685e-01 | 0.365 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 4.313685e-01 | 0.365 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 4.335654e-01 | 0.363 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 4.335654e-01 | 0.363 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 4.335654e-01 | 0.363 | 0 | 0 |
| SLBP independent Processing of Histone Pre-mRNAs | R-HSA-111367 | 4.335654e-01 | 0.363 | 0 | 0 |
| Reuptake of GABA | R-HSA-888593 | 4.335654e-01 | 0.363 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 4.335654e-01 | 0.363 | 0 | 0 |
| LDL remodeling | R-HSA-8964041 | 4.335654e-01 | 0.363 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 4.335654e-01 | 0.363 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 4.335654e-01 | 0.363 | 0 | 0 |
| Maturation of replicase proteins | R-HSA-9694301 | 4.335654e-01 | 0.363 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 4.339582e-01 | 0.363 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 4.339582e-01 | 0.363 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 4.347003e-01 | 0.362 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 4.347003e-01 | 0.362 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 4.347003e-01 | 0.362 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 4.347003e-01 | 0.362 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 4.347003e-01 | 0.362 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 4.347003e-01 | 0.362 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 4.417246e-01 | 0.355 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 4.417246e-01 | 0.355 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 4.417246e-01 | 0.355 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 4.417246e-01 | 0.355 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 4.420809e-01 | 0.354 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 4.438423e-01 | 0.353 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 4.438423e-01 | 0.353 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 4.438423e-01 | 0.353 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 4.442423e-01 | 0.352 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 4.464092e-01 | 0.350 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 4.515375e-01 | 0.345 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 4.534525e-01 | 0.343 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 4.536989e-01 | 0.343 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 4.536989e-01 | 0.343 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 4.536989e-01 | 0.343 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 4.551609e-01 | 0.342 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 4.562318e-01 | 0.341 | 0 | 0 |
| phospho-PLA2 pathway | R-HSA-111995 | 4.648737e-01 | 0.333 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 4.648737e-01 | 0.333 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 4.648737e-01 | 0.333 | 0 | 0 |
| SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | R-HSA-77588 | 4.648737e-01 | 0.333 | 0 | 0 |
| Fructose biosynthesis | R-HSA-5652227 | 4.648737e-01 | 0.333 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 4.648737e-01 | 0.333 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 4.648737e-01 | 0.333 | 0 | 0 |
| Interleukin-23 signaling | R-HSA-9020933 | 4.648737e-01 | 0.333 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 4.660195e-01 | 0.332 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 4.660195e-01 | 0.332 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 4.660195e-01 | 0.332 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 4.673574e-01 | 0.330 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 4.685274e-01 | 0.329 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 4.685274e-01 | 0.329 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 4.723261e-01 | 0.326 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 4.723261e-01 | 0.326 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 4.723261e-01 | 0.326 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 4.723261e-01 | 0.326 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 4.723261e-01 | 0.326 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 4.723261e-01 | 0.326 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 4.768115e-01 | 0.322 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 4.807202e-01 | 0.318 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 4.847424e-01 | 0.314 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 4.852487e-01 | 0.314 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 4.852487e-01 | 0.314 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 4.852487e-01 | 0.314 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 4.887319e-01 | 0.311 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 4.905649e-01 | 0.309 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 4.905649e-01 | 0.309 | 0 | 0 |
| Synthesis of pyrophosphates in the cytosol | R-HSA-1855167 | 4.905649e-01 | 0.309 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 4.905649e-01 | 0.309 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 4.905649e-01 | 0.309 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 4.928016e-01 | 0.307 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 4.928016e-01 | 0.307 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 4.941361e-01 | 0.306 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 4.944532e-01 | 0.306 | 0 | 0 |
| mRNA Editing | R-HSA-75072 | 4.944532e-01 | 0.306 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 4.944532e-01 | 0.306 | 0 | 0 |
| Regulation of NPAS4 gene transcription | R-HSA-9768777 | 4.944532e-01 | 0.306 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 4.944532e-01 | 0.306 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 4.970290e-01 | 0.304 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 4.981703e-01 | 0.303 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 4.993933e-01 | 0.302 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 4.993933e-01 | 0.302 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 4.993933e-01 | 0.302 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 5.006514e-01 | 0.300 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 5.023780e-01 | 0.299 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 5.066304e-01 | 0.295 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 5.084013e-01 | 0.294 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 5.084013e-01 | 0.294 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 5.084013e-01 | 0.294 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 5.084013e-01 | 0.294 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 5.087251e-01 | 0.294 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 5.133378e-01 | 0.290 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 5.133378e-01 | 0.290 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 5.139411e-01 | 0.289 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 5.165992e-01 | 0.287 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 5.170659e-01 | 0.286 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 5.181618e-01 | 0.286 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 5.223994e-01 | 0.282 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 5.223994e-01 | 0.282 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 5.223994e-01 | 0.282 | 0 | 0 |
| DNA replication initiation | R-HSA-68952 | 5.223994e-01 | 0.282 | 0 | 0 |
| Metal sequestration by antimicrobial proteins | R-HSA-6799990 | 5.223994e-01 | 0.282 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 5.223994e-01 | 0.282 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 5.223994e-01 | 0.282 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 5.223994e-01 | 0.282 | 0 | 0 |
| Defective factor IX causes hemophilia B | R-HSA-9668250 | 5.223994e-01 | 0.282 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 5.223994e-01 | 0.282 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 5.223994e-01 | 0.282 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 5.223994e-01 | 0.282 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 5.233934e-01 | 0.281 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 5.258241e-01 | 0.279 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 5.258241e-01 | 0.279 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 5.258241e-01 | 0.279 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 5.258241e-01 | 0.279 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 5.258241e-01 | 0.279 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 5.258241e-01 | 0.279 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 5.258241e-01 | 0.279 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 5.258241e-01 | 0.279 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 5.270729e-01 | 0.278 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 5.283011e-01 | 0.277 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 5.283011e-01 | 0.277 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 5.283011e-01 | 0.277 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 5.368152e-01 | 0.270 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 5.398262e-01 | 0.268 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 5.398631e-01 | 0.268 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 5.405902e-01 | 0.267 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 5.406792e-01 | 0.267 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 5.406792e-01 | 0.267 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 5.421728e-01 | 0.266 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 5.428245e-01 | 0.265 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 5.428245e-01 | 0.265 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 5.428245e-01 | 0.265 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 5.428245e-01 | 0.265 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 5.428245e-01 | 0.265 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 5.436426e-01 | 0.265 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 5.488024e-01 | 0.261 | 0 | 0 |
| Conjugation of benzoate with glycine | R-HSA-177135 | 5.488024e-01 | 0.261 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 5.488024e-01 | 0.261 | 0 | 0 |
| Chylomicron assembly | R-HSA-8963888 | 5.488024e-01 | 0.261 | 0 | 0 |
| Synthesis of PI | R-HSA-1483226 | 5.488024e-01 | 0.261 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 5.488024e-01 | 0.261 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 5.488024e-01 | 0.261 | 0 | 0 |
| Prostanoid ligand receptors | R-HSA-391908 | 5.488024e-01 | 0.261 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 5.538822e-01 | 0.257 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 5.538822e-01 | 0.257 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 5.593960e-01 | 0.252 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 5.593960e-01 | 0.252 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 5.600422e-01 | 0.252 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 5.625441e-01 | 0.250 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 5.625441e-01 | 0.250 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 5.625441e-01 | 0.250 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 5.669423e-01 | 0.246 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 5.669423e-01 | 0.246 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 5.669423e-01 | 0.246 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 5.669423e-01 | 0.246 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 5.699818e-01 | 0.244 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 5.736528e-01 | 0.241 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 5.736528e-01 | 0.241 | 0 | 0 |
| Anchoring fibril formation | R-HSA-2214320 | 5.737473e-01 | 0.241 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 5.737473e-01 | 0.241 | 0 | 0 |
| Endosomal/Vacuolar pathway | R-HSA-1236977 | 5.737473e-01 | 0.241 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 5.737473e-01 | 0.241 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 5.737473e-01 | 0.241 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 5.737473e-01 | 0.241 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 5.737473e-01 | 0.241 | 0 | 0 |
| Viral RNP Complexes in the Host Cell Nucleus | R-HSA-168330 | 5.737473e-01 | 0.241 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 5.737473e-01 | 0.241 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 5.737473e-01 | 0.241 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 5.737473e-01 | 0.241 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 5.744420e-01 | 0.241 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 5.755341e-01 | 0.240 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 5.755341e-01 | 0.240 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 5.755341e-01 | 0.240 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 5.757631e-01 | 0.240 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 5.797649e-01 | 0.237 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 5.797649e-01 | 0.237 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 5.797649e-01 | 0.237 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 5.846008e-01 | 0.233 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 5.855186e-01 | 0.232 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 5.912360e-01 | 0.228 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 5.912360e-01 | 0.228 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 5.912360e-01 | 0.228 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 5.923452e-01 | 0.227 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 5.953842e-01 | 0.225 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 5.973145e-01 | 0.224 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 5.973145e-01 | 0.224 | 0 | 0 |
| Conjugation of salicylate with glycine | R-HSA-177128 | 5.973145e-01 | 0.224 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 5.973145e-01 | 0.224 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 5.973145e-01 | 0.224 | 0 | 0 |
| Trafficking and processing of endosomal TLR | R-HSA-1679131 | 5.973145e-01 | 0.224 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 5.973145e-01 | 0.224 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 5.973145e-01 | 0.224 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 5.973145e-01 | 0.224 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 5.973145e-01 | 0.224 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 5.973145e-01 | 0.224 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 5.973145e-01 | 0.224 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 5.973145e-01 | 0.224 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 5.973145e-01 | 0.224 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 5.973145e-01 | 0.224 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 5.973145e-01 | 0.224 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 6.007318e-01 | 0.221 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 6.065007e-01 | 0.217 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 6.164427e-01 | 0.210 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 6.178533e-01 | 0.209 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 6.195800e-01 | 0.208 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 6.195800e-01 | 0.208 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 6.195800e-01 | 0.208 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 6.195800e-01 | 0.208 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 6.213284e-01 | 0.207 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 6.213284e-01 | 0.207 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 6.213284e-01 | 0.207 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 6.227536e-01 | 0.206 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 6.267118e-01 | 0.203 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 6.270415e-01 | 0.203 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 6.285943e-01 | 0.202 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 6.285943e-01 | 0.202 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 6.285943e-01 | 0.202 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 6.305056e-01 | 0.200 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 6.357208e-01 | 0.197 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 6.400459e-01 | 0.194 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 6.400459e-01 | 0.194 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 6.401713e-01 | 0.194 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 6.406157e-01 | 0.193 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 6.406157e-01 | 0.193 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 6.406157e-01 | 0.193 | 0 | 0 |
| Synthesis of IPs in the nucleus | R-HSA-1855191 | 6.406157e-01 | 0.193 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 6.406157e-01 | 0.193 | 0 | 0 |
| Hydrolysis of LPC | R-HSA-1483115 | 6.406157e-01 | 0.193 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 6.406157e-01 | 0.193 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 6.406157e-01 | 0.193 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 6.406157e-01 | 0.193 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 6.406157e-01 | 0.193 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 6.406157e-01 | 0.193 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 6.406157e-01 | 0.193 | 0 | 0 |
| Acyl chain remodeling of CL | R-HSA-1482798 | 6.406157e-01 | 0.193 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 6.406157e-01 | 0.193 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 6.467176e-01 | 0.189 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 6.467176e-01 | 0.189 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 6.467176e-01 | 0.189 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 6.496807e-01 | 0.187 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 6.496807e-01 | 0.187 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 6.496807e-01 | 0.187 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 6.564504e-01 | 0.183 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 6.604893e-01 | 0.180 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 6.604893e-01 | 0.180 | 0 | 0 |
| Protein lipoylation | R-HSA-9857492 | 6.604893e-01 | 0.180 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 6.604893e-01 | 0.180 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 6.604893e-01 | 0.180 | 0 | 0 |
| Signaling by Activin | R-HSA-1502540 | 6.604893e-01 | 0.180 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 6.604893e-01 | 0.180 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 6.604893e-01 | 0.180 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 6.604893e-01 | 0.180 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 6.604893e-01 | 0.180 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 6.604893e-01 | 0.180 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 6.604893e-01 | 0.180 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 6.604893e-01 | 0.180 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 6.624312e-01 | 0.179 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 6.625566e-01 | 0.179 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 6.625566e-01 | 0.179 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 6.632119e-01 | 0.178 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 6.632119e-01 | 0.178 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 6.632119e-01 | 0.178 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 6.632119e-01 | 0.178 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 6.678930e-01 | 0.175 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 6.678930e-01 | 0.175 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 6.678930e-01 | 0.175 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 6.763192e-01 | 0.170 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 6.763192e-01 | 0.170 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 6.763192e-01 | 0.170 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 6.763192e-01 | 0.170 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 6.763192e-01 | 0.170 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 6.763192e-01 | 0.170 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 6.763192e-01 | 0.170 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 6.763192e-01 | 0.170 | 0 | 0 |
| Entry of Influenza Virion into Host Cell via Endocytosis | R-HSA-168275 | 6.792652e-01 | 0.168 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 6.792652e-01 | 0.168 | 0 | 0 |
| Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion | R-HSA-434316 | 6.792652e-01 | 0.168 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 6.792652e-01 | 0.168 | 0 | 0 |
| Attachment and Entry | R-HSA-9678110 | 6.792652e-01 | 0.168 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 6.890080e-01 | 0.162 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 6.890080e-01 | 0.162 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 6.890080e-01 | 0.162 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 6.890080e-01 | 0.162 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 6.890080e-01 | 0.162 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 6.915119e-01 | 0.160 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 6.970037e-01 | 0.157 | 0 | 0 |
| Glycine degradation | R-HSA-6783984 | 6.970037e-01 | 0.157 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 6.970037e-01 | 0.157 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 6.970037e-01 | 0.157 | 0 | 0 |
| Galactose catabolism | R-HSA-70370 | 6.970037e-01 | 0.157 | 0 | 0 |
| Coenzyme A biosynthesis | R-HSA-196783 | 6.970037e-01 | 0.157 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 6.970037e-01 | 0.157 | 0 | 0 |
| tRNA modification in the mitochondrion | R-HSA-6787450 | 6.970037e-01 | 0.157 | 0 | 0 |
| Defects of contact activation system (CAS) and kallikrein/kinin system (KKS) | R-HSA-9651496 | 6.970037e-01 | 0.157 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 7.012844e-01 | 0.154 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 7.012844e-01 | 0.154 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 7.012844e-01 | 0.154 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 7.012844e-01 | 0.154 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 7.012844e-01 | 0.154 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 7.034944e-01 | 0.153 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 7.034944e-01 | 0.153 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 7.112751e-01 | 0.148 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 7.131554e-01 | 0.147 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 7.131554e-01 | 0.147 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 7.131554e-01 | 0.147 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 7.131554e-01 | 0.147 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 7.132328e-01 | 0.147 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 7.137622e-01 | 0.146 | 0 | 0 |
| Sulfide oxidation to sulfate | R-HSA-1614517 | 7.137622e-01 | 0.146 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 7.137622e-01 | 0.146 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 7.137622e-01 | 0.146 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 7.137622e-01 | 0.146 | 0 | 0 |
| Metabolism of ingested H2SeO4 and H2SeO3 into H2Se | R-HSA-2408550 | 7.137622e-01 | 0.146 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 7.137622e-01 | 0.146 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 7.137622e-01 | 0.146 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 7.235642e-01 | 0.141 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 7.246281e-01 | 0.140 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 7.246281e-01 | 0.140 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 7.271178e-01 | 0.138 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 7.289926e-01 | 0.137 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 7.289926e-01 | 0.137 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 7.294562e-01 | 0.137 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 7.295948e-01 | 0.137 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 7.295948e-01 | 0.137 | 0 | 0 |
| PKA activation | R-HSA-163615 | 7.295948e-01 | 0.137 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 7.295948e-01 | 0.137 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 7.295948e-01 | 0.137 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 7.295948e-01 | 0.137 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 7.295948e-01 | 0.137 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 7.295948e-01 | 0.137 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 7.295948e-01 | 0.137 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 7.337486e-01 | 0.134 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 7.338809e-01 | 0.134 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 7.352778e-01 | 0.134 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 7.357104e-01 | 0.133 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 7.357104e-01 | 0.133 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 7.405245e-01 | 0.130 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 7.418826e-01 | 0.130 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 7.418826e-01 | 0.130 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 7.436843e-01 | 0.129 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 7.445525e-01 | 0.128 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 7.445525e-01 | 0.128 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 7.445525e-01 | 0.128 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 7.445525e-01 | 0.128 | 0 | 0 |
| Pyrimidine biosynthesis | R-HSA-500753 | 7.445525e-01 | 0.128 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 7.445525e-01 | 0.128 | 0 | 0 |
| Conjugation of carboxylic acids | R-HSA-159424 | 7.445525e-01 | 0.128 | 0 | 0 |
| Amino Acid conjugation | R-HSA-156587 | 7.445525e-01 | 0.128 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 7.445525e-01 | 0.128 | 0 | 0 |
| Methionine salvage pathway | R-HSA-1237112 | 7.445525e-01 | 0.128 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 7.445525e-01 | 0.128 | 0 | 0 |
| Diseases of hemostasis | R-HSA-9671793 | 7.445525e-01 | 0.128 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 7.445525e-01 | 0.128 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 7.445525e-01 | 0.128 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 7.445525e-01 | 0.128 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 7.464102e-01 | 0.127 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 7.464102e-01 | 0.127 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 7.514009e-01 | 0.124 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 7.533763e-01 | 0.123 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 7.549231e-01 | 0.122 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 7.567359e-01 | 0.121 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 7.567359e-01 | 0.121 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 7.567359e-01 | 0.121 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 7.586837e-01 | 0.120 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 7.586837e-01 | 0.120 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 7.586837e-01 | 0.120 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 7.586837e-01 | 0.120 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 7.586837e-01 | 0.120 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 7.586837e-01 | 0.120 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 7.586837e-01 | 0.120 | 0 | 0 |
| Mitochondrial iron-sulfur cluster biogenesis | R-HSA-1362409 | 7.586837e-01 | 0.120 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 7.586837e-01 | 0.120 | 0 | 0 |
| Acyl chain remodelling of PI | R-HSA-1482922 | 7.586837e-01 | 0.120 | 0 | 0 |
| Pregnenolone biosynthesis | R-HSA-196108 | 7.586837e-01 | 0.120 | 0 | 0 |
| Eicosanoid ligand-binding receptors | R-HSA-391903 | 7.586837e-01 | 0.120 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 7.592223e-01 | 0.120 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 7.592223e-01 | 0.120 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 7.616949e-01 | 0.118 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 7.643568e-01 | 0.117 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 7.666963e-01 | 0.115 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 7.666963e-01 | 0.115 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 7.666963e-01 | 0.115 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 7.675326e-01 | 0.115 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 7.708481e-01 | 0.113 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 7.720339e-01 | 0.112 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 7.720339e-01 | 0.112 | 0 | 0 |
| Intrinsic Pathway of Fibrin Clot Formation | R-HSA-140837 | 7.720339e-01 | 0.112 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 7.720339e-01 | 0.112 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 7.720339e-01 | 0.112 | 0 | 0 |
| Acyl chain remodelling of PG | R-HSA-1482925 | 7.720339e-01 | 0.112 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 7.763000e-01 | 0.110 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 7.804860e-01 | 0.108 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 7.846464e-01 | 0.105 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 7.846464e-01 | 0.105 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 7.846464e-01 | 0.105 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 7.846464e-01 | 0.105 | 0 | 0 |
| Serine metabolism | R-HSA-977347 | 7.846464e-01 | 0.105 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 7.846464e-01 | 0.105 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 7.846464e-01 | 0.105 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 7.846464e-01 | 0.105 | 0 | 0 |
| Ribavirin ADME | R-HSA-9755088 | 7.846464e-01 | 0.105 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 7.855560e-01 | 0.105 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 7.873204e-01 | 0.104 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 7.873380e-01 | 0.104 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 7.910665e-01 | 0.102 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 7.944735e-01 | 0.100 | 0 | 0 |
| Methylation | R-HSA-156581 | 7.944735e-01 | 0.100 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 7.965617e-01 | 0.099 | 0 | 0 |
| WNT ligand biogenesis and trafficking | R-HSA-3238698 | 7.965617e-01 | 0.099 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 7.965617e-01 | 0.099 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 7.965617e-01 | 0.099 | 0 | 0 |
| Fructose metabolism | R-HSA-5652084 | 7.965617e-01 | 0.099 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 7.965617e-01 | 0.099 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 7.965617e-01 | 0.099 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 7.965617e-01 | 0.099 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 7.984578e-01 | 0.098 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 8.030615e-01 | 0.095 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 8.030615e-01 | 0.095 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 8.030615e-01 | 0.095 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 8.030615e-01 | 0.095 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 8.030615e-01 | 0.095 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 8.030615e-01 | 0.095 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 8.078185e-01 | 0.093 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 8.078185e-01 | 0.093 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 8.078185e-01 | 0.093 | 0 | 0 |
| Mitochondrial mRNA modification | R-HSA-9937008 | 8.078185e-01 | 0.093 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 8.113291e-01 | 0.091 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 8.113291e-01 | 0.091 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 8.129703e-01 | 0.090 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 8.184531e-01 | 0.087 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 8.184531e-01 | 0.087 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 8.184531e-01 | 0.087 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 8.184531e-01 | 0.087 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 8.184531e-01 | 0.087 | 0 | 0 |
| Assembly of active LPL and LIPC lipase complexes | R-HSA-8963889 | 8.184531e-01 | 0.087 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 8.184531e-01 | 0.087 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 8.184531e-01 | 0.087 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 8.184531e-01 | 0.087 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 8.184531e-01 | 0.087 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 8.184531e-01 | 0.087 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 8.184531e-01 | 0.087 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 8.192856e-01 | 0.087 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 8.258633e-01 | 0.083 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 8.268960e-01 | 0.083 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 8.269399e-01 | 0.083 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 8.269399e-01 | 0.083 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 8.269399e-01 | 0.083 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 8.284998e-01 | 0.082 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 8.284998e-01 | 0.082 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 8.284998e-01 | 0.082 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 8.284998e-01 | 0.082 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 8.284998e-01 | 0.082 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 8.379911e-01 | 0.077 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 8.379911e-01 | 0.077 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 8.379911e-01 | 0.077 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 8.383294e-01 | 0.077 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 8.413785e-01 | 0.075 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 8.413785e-01 | 0.075 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 8.434429e-01 | 0.074 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 8.469576e-01 | 0.072 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 8.469576e-01 | 0.072 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 8.469576e-01 | 0.072 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 8.469576e-01 | 0.072 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 8.469576e-01 | 0.072 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 8.469576e-01 | 0.072 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 8.469576e-01 | 0.072 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 8.469576e-01 | 0.072 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 8.469576e-01 | 0.072 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 8.469576e-01 | 0.072 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 8.481805e-01 | 0.072 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 8.481805e-01 | 0.072 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 8.482949e-01 | 0.071 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 8.486179e-01 | 0.071 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 8.500173e-01 | 0.071 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 8.547162e-01 | 0.068 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 8.554284e-01 | 0.068 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 8.554284e-01 | 0.068 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 8.554284e-01 | 0.068 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 8.566656e-01 | 0.067 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 8.566656e-01 | 0.067 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 8.609940e-01 | 0.065 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 8.609940e-01 | 0.065 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 8.634309e-01 | 0.064 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 8.634309e-01 | 0.064 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 8.634309e-01 | 0.064 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 8.661271e-01 | 0.062 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 8.661678e-01 | 0.062 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 8.661678e-01 | 0.062 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 8.676612e-01 | 0.062 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 8.709908e-01 | 0.060 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 8.709908e-01 | 0.060 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 8.709908e-01 | 0.060 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 8.709908e-01 | 0.060 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 8.709908e-01 | 0.060 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 8.728102e-01 | 0.059 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 8.736704e-01 | 0.059 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 8.760653e-01 | 0.057 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 8.781327e-01 | 0.056 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 8.781327e-01 | 0.056 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 8.781327e-01 | 0.056 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 8.781327e-01 | 0.056 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 8.781327e-01 | 0.056 | 0 | 0 |
| Disease | R-HSA-1643685 | 8.824660e-01 | 0.054 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 8.836953e-01 | 0.054 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 8.848796e-01 | 0.053 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 8.888086e-01 | 0.051 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 8.896950e-01 | 0.051 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 8.912534e-01 | 0.050 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 8.912534e-01 | 0.050 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 8.912534e-01 | 0.050 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 8.912534e-01 | 0.050 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 8.912534e-01 | 0.050 | 0 | 0 |
| Recycling of bile acids and salts | R-HSA-159418 | 8.912534e-01 | 0.050 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 8.919412e-01 | 0.050 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 8.937126e-01 | 0.049 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 8.972746e-01 | 0.047 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 8.972746e-01 | 0.047 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 8.972746e-01 | 0.047 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 8.972746e-01 | 0.047 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 8.972746e-01 | 0.047 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 8.972746e-01 | 0.047 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 8.984149e-01 | 0.047 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 8.984149e-01 | 0.047 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.029228e-01 | 0.044 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 9.029228e-01 | 0.044 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 9.029628e-01 | 0.044 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 9.029628e-01 | 0.044 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 9.029628e-01 | 0.044 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 9.029628e-01 | 0.044 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 9.029628e-01 | 0.044 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.057759e-01 | 0.043 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 9.072433e-01 | 0.042 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 9.083364e-01 | 0.042 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.083364e-01 | 0.042 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 9.113056e-01 | 0.040 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 9.134127e-01 | 0.039 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 9.134127e-01 | 0.039 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 9.134127e-01 | 0.039 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 9.153498e-01 | 0.038 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 9.182081e-01 | 0.037 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 9.182081e-01 | 0.037 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 9.182081e-01 | 0.037 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 9.182081e-01 | 0.037 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 9.197056e-01 | 0.036 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 9.208978e-01 | 0.036 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 9.208978e-01 | 0.036 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.217173e-01 | 0.035 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 9.227383e-01 | 0.035 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 9.227383e-01 | 0.035 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 9.227383e-01 | 0.035 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 9.270178e-01 | 0.033 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.288898e-01 | 0.032 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.294790e-01 | 0.032 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.296061e-01 | 0.032 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 9.296061e-01 | 0.032 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 9.296061e-01 | 0.032 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 9.310605e-01 | 0.031 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 9.310605e-01 | 0.031 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 9.310605e-01 | 0.031 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 9.310605e-01 | 0.031 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 9.310605e-01 | 0.031 | 0 | 0 |
| Maturation of TCA enzymes and regulation of TCA cycle | R-HSA-9854311 | 9.310605e-01 | 0.031 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 9.310605e-01 | 0.031 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 9.348795e-01 | 0.029 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 9.348795e-01 | 0.029 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.358528e-01 | 0.029 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 9.384871e-01 | 0.028 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 9.384871e-01 | 0.028 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 9.384871e-01 | 0.028 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 9.384871e-01 | 0.028 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 9.384871e-01 | 0.028 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 9.384871e-01 | 0.028 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 9.393527e-01 | 0.027 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 9.418951e-01 | 0.026 | 0 | 0 |
| Aspirin ADME | R-HSA-9749641 | 9.442460e-01 | 0.025 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 9.451145e-01 | 0.025 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 9.481557e-01 | 0.023 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 9.481557e-01 | 0.023 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.492492e-01 | 0.023 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 9.492492e-01 | 0.023 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 9.510285e-01 | 0.022 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 9.510285e-01 | 0.022 | 0 | 0 |
| Degradation of cysteine and homocysteine | R-HSA-1614558 | 9.510285e-01 | 0.022 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 9.510285e-01 | 0.022 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 9.537424e-01 | 0.021 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 9.537424e-01 | 0.021 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 9.537424e-01 | 0.021 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 9.537424e-01 | 0.021 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 9.537424e-01 | 0.021 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 9.537424e-01 | 0.021 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 9.538224e-01 | 0.021 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.539872e-01 | 0.020 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 9.559586e-01 | 0.020 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 9.563059e-01 | 0.019 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.585811e-01 | 0.018 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 9.602669e-01 | 0.018 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 9.602669e-01 | 0.018 | 0 | 0 |
| Glyoxylate metabolism and glycine degradation | R-HSA-389661 | 9.610152e-01 | 0.017 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 9.610152e-01 | 0.017 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.610152e-01 | 0.017 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 9.643018e-01 | 0.016 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 9.652174e-01 | 0.015 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 9.652948e-01 | 0.015 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 9.684692e-01 | 0.014 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 9.684717e-01 | 0.014 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.684717e-01 | 0.014 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 9.689671e-01 | 0.014 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.692504e-01 | 0.014 | 0 | 0 |
| Sulfur amino acid metabolism | R-HSA-1614635 | 9.713631e-01 | 0.013 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 9.713777e-01 | 0.013 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.717918e-01 | 0.012 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 9.723129e-01 | 0.012 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 9.727122e-01 | 0.012 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 9.738481e-01 | 0.012 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.776452e-01 | 0.010 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.779622e-01 | 0.010 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.781906e-01 | 0.010 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.791845e-01 | 0.009 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 9.795893e-01 | 0.009 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 9.803391e-01 | 0.009 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.804021e-01 | 0.009 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 9.814297e-01 | 0.008 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.815038e-01 | 0.008 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.824598e-01 | 0.008 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.825669e-01 | 0.008 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 9.831406e-01 | 0.007 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.831406e-01 | 0.007 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.839807e-01 | 0.007 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.843327e-01 | 0.007 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.860403e-01 | 0.006 | 0 | 0 |
| Metabolism of steroid hormones | R-HSA-196071 | 9.860403e-01 | 0.006 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 9.860415e-01 | 0.006 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 9.860415e-01 | 0.006 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 9.860415e-01 | 0.006 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.862246e-01 | 0.006 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.871472e-01 | 0.006 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.888906e-01 | 0.005 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.888906e-01 | 0.005 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 9.895072e-01 | 0.005 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 9.897644e-01 | 0.004 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 9.897977e-01 | 0.004 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.906398e-01 | 0.004 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 9.921138e-01 | 0.003 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.927815e-01 | 0.003 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.929652e-01 | 0.003 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 9.929652e-01 | 0.003 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.946602e-01 | 0.002 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.946602e-01 | 0.002 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.948685e-01 | 0.002 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.949235e-01 | 0.002 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.949235e-01 | 0.002 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.952327e-01 | 0.002 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.959457e-01 | 0.002 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.959938e-01 | 0.002 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 9.960276e-01 | 0.002 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.961162e-01 | 0.002 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.962382e-01 | 0.002 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.964568e-01 | 0.002 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.969260e-01 | 0.001 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.970153e-01 | 0.001 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.971193e-01 | 0.001 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.971812e-01 | 0.001 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.971812e-01 | 0.001 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 9.972016e-01 | 0.001 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.975694e-01 | 0.001 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 9.977484e-01 | 0.001 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 9.977576e-01 | 0.001 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.979675e-01 | 0.001 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 9.980146e-01 | 0.001 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 9.984092e-01 | 0.001 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 9.993477e-01 | 0.000 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.994324e-01 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 9.995042e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.996792e-01 | 0.000 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 9.997306e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.998963e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.999192e-01 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 9.999540e-01 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.999571e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.999787e-01 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 9.999819e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999907e-01 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 9.999964e-01 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 9.999999e-01 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 9.999999e-01 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |